meta-reg-snw-5887
Interacting subnets
| Subnetwork | Dataset | Score | p-value 1 | p-value 2 | p-value 3 | Size | Highlighted genes |
|---|---|---|---|---|---|---|---|
| int-snw-51477 | wolf-screen-ratio-mammosphere-adherent | 0.934 | 1.79e-15 | 2.53e-03 | 4.07e-02 | 9 | 8 |
| reg-snw-5887 | wolf-screen-ratio-mammosphere-adherent | 0.858 | 2.95e-07 | 1.57e-03 | 3.19e-03 | 5 | 5 |
| int-snw-2064 | wolf-screen-ratio-mammosphere-adherent | 0.950 | 4.36e-16 | 1.79e-03 | 3.17e-02 | 15 | 15 |
| int-snw-5216 | wolf-screen-ratio-mammosphere-adherent | 1.002 | 3.25e-18 | 5.25e-04 | 1.26e-02 | 12 | 11 |
| int-snw-1120 | wolf-screen-ratio-mammosphere-adherent | 0.934 | 1.80e-15 | 2.53e-03 | 4.08e-02 | 16 | 15 |
| int-snw-5743 | wolf-screen-ratio-mammosphere-adherent | 0.944 | 7.33e-16 | 2.03e-03 | 3.48e-02 | 12 | 11 |
| int-snw-6446 | wolf-screen-ratio-mammosphere-adherent | 0.930 | 2.55e-15 | 2.75e-03 | 4.33e-02 | 18 | 18 |
Genes (37)
| Gene Symbol | Entrez Gene ID | Frequency | wolf-screen-ratio-mammosphere-adherent gene score | Best subnetwork score | Degree | wolf adherent-list Hits GI | wolf mammosphere no adherent-list Hits GI |
|---|---|---|---|---|---|---|---|
| PSMA2 | 5683 | 112 | 1.093 | 1.106 | 108 | Yes | - |
| TP53 | 7157 | 23 | 0.432 | 0.833 | 665 | - | - |
| ERBB2 | 2064 | 10 | 0.004 | 0.950 | 156 | Yes | - |
| VARS | 7407 | 86 | 0.549 | 1.002 | 204 | Yes | - |
| CHKB | 1120 | 12 | -0.169 | 0.934 | 42 | - | Yes |
| ISYNA1 | 51477 | 3 | -0.120 | 0.934 | 48 | - | - |
| ATP6V1B2 | 526 | 53 | 0.881 | 1.076 | 278 | - | - |
| RPA2 | 6118 | 96 | 1.250 | 1.151 | 76 | Yes | - |
| PSMA6 | 5687 | 19 | 0.691 | 0.956 | 137 | Yes | - |
| PSMD1 | 5707 | 86 | 0.836 | 0.830 | 118 | Yes | - |
| EIF2S2 | 8894 | 39 | 1.075 | 0.940 | 103 | Yes | - |
| EEF2 | 1938 | 64 | 0.890 | 1.043 | 301 | Yes | - |
| PFN1 | 5216 | 10 | -0.143 | 1.002 | 78 | - | - |
| RPS11 | 6205 | 62 | 0.993 | 1.113 | 175 | Yes | - |
| RAD23B | 5887 | 7 | 0.158 | 0.858 | 11 | Yes | - |
| EFTUD2 | 9343 | 93 | 0.883 | 0.956 | 108 | Yes | - |
| SGK1 | 6446 | 17 | -0.189 | 0.930 | 76 | - | Yes |
| TUBG1 | 7283 | 98 | 0.974 | 0.973 | 91 | Yes | - |
| PSMD11 | 5717 | 124 | 1.095 | 1.106 | 218 | Yes | - |
| KPNB1 | 3837 | 17 | 0.613 | 1.017 | 296 | Yes | - |
| ITK | 3702 | 15 | 0.602 | 0.950 | 39 | Yes | - |
| RBX1 | 9978 | 115 | 1.185 | 0.934 | 148 | Yes | - |
| PSMB7 | 5695 | 118 | 0.982 | 0.934 | 90 | Yes | - |
| PSMA1 | 5682 | 100 | 0.996 | 0.878 | 152 | Yes | - |
| RPSA | 3921 | 120 | 1.327 | 1.151 | 152 | Yes | - |
| RPS3A | 6189 | 40 | 0.835 | 1.069 | 166 | Yes | - |
| PGD | 5226 | 89 | 1.201 | 1.106 | 152 | Yes | - |
| PTGS2 | 5743 | 11 | -0.242 | 0.944 | 14 | - | Yes |
| ACO2 | 50 | 65 | 1.000 | 1.076 | 191 | Yes | - |
| CDC16 | 8881 | 53 | 0.950 | 1.020 | 80 | Yes | - |
| PSMD3 | 5709 | 100 | 0.986 | 1.106 | 201 | Yes | - |
| CLTC | 1213 | 56 | 0.884 | 1.138 | 247 | Yes | - |
| RPL14 | 9045 | 49 | 1.250 | 1.113 | 166 | Yes | - |
| GSK3B | 2932 | 22 | 0.475 | 0.934 | 319 | - | Yes |
| ACTB | 60 | 134 | 1.153 | 1.151 | 610 | Yes | - |
| SAP18 | 10284 | 20 | 1.115 | 1.069 | 57 | Yes | - |
| PSMD6 | 9861 | 79 | 0.848 | 0.878 | 143 | Yes | - |
Interactions (113)
| Gene Symbol 1 | Entrez Gene ID 1 | Gene Symbol 2 | Entrez Gene ID 2 | Type | Direction | Origin databases / Sources |
|---|---|---|---|---|---|---|
| PSMD1 | 5707 | RAD23B | 5887 | pp | -- | int.I2D: BioGrid_Yeast, IntAct_Rat, IntAct_Yeast, Krogan_Core, MINT, MINT_Yeast; int.Mint: MI:0915(physical association) |
| PSMD11 | 5717 | PSMD6 | 9861 | pp | -- | int.Proteinpedia: Mass spectrometry; int.Intact: MI:0915(physical association); int.I2D: BioGrid_Yeast, IntAct, IntAct_Yeast, Krogan_Core, MINT_Yeast, YeastHigh, BioGrid, INTEROLOG |
| SGK1 | 6446 | PSMD6 | 9861 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: IntAct |
| EEF2 | 1938 | PGD | 5226 | pp | -- | int.I2D: BioGrid_Yeast |
| RAD23B | 5887 | PSMD6 | 9861 | pp | -- | int.I2D: MINT; int.Mint: MI:0915(physical association) |
| PSMA6 | 5687 | RBX1 | 9978 | pp | -- | int.I2D: BioGrid |
| GSK3B | 2932 | TP53 | 7157 | pp | -- | int.I2D: BIND, MINT, BCI, BioGrid, HPRD; int.Mint: MI:0915(physical association), MI:0217(phosphorylation reaction); int.HPRD: in vitro, in vivo |
| EEF2 | 1938 | ISYNA1 | 51477 | pp | -- | int.I2D: BioGrid_Yeast, MINT_Yeast, Tarassov_PCA, IntAct_Yeast |
| PSMD11 | 5717 | RAD23B | 5887 | pp | -- | int.I2D: YeastLow, BioGrid_Yeast, IntAct_Yeast, MINT_Yeast |
| PSMD1 | 5707 | PSMD3 | 5709 | pp | -- | int.I2D: BioGrid_Yeast, MINT_Yeast, Krogan_Core |
| KPNB1 | 3837 | TP53 | 7157 | pp | -- | int.I2D: BioGrid, HPRD; int.HPRD: in vivo |
| ACTB | 60 | CLTC | 1213 | pp | -- | int.I2D: IntAct_Yeast |
| PFN1 | 5216 | TP53 | 7157 | pd | < | reg.ITFP.txt: no annot |
| ACTB | 60 | KPNB1 | 3837 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: IntAct |
| PSMB7 | 5695 | PSMD3 | 5709 | pp | -- | int.I2D: BioGrid_Yeast |
| PSMA2 | 5683 | PSMB7 | 5695 | pp | -- | int.Intact: MI:0914(association); int.I2D: BCI, BioGrid, BioGrid_Yeast, BIND_Yeast, IntAct, Krogan_Core, MINT_Yeast, YeastLow, IntAct_Yeast |
| PSMB7 | 5695 | RAD23B | 5887 | pp | -- | int.I2D: BioGrid_Yeast, BIND_Yeast, MIPS |
| GSK3B | 2932 | SGK1 | 6446 | pp | -- | int.I2D: HPRD, BCI; int.HPRD: in vitro, in vivo |
| PSMA2 | 5683 | PSMD1 | 5707 | pp | -- | int.I2D: BioGrid_Yeast |
| PSMD3 | 5709 | RAD23B | 5887 | pd | > | reg.ITFP.txt: no annot |
| PSMD3 | 5709 | RAD23B | 5887 | pp | -- | int.I2D: YeastLow, BioGrid_Yeast, IntAct_Yeast, MINT_Yeast |
| PTGS2 | 5743 | TP53 | 7157 | pp | -- | int.I2D: BioGrid, BIND, HPRD; int.HPRD: in vivo |
| PSMA2 | 5683 | PSMD11 | 5717 | pp | -- | int.I2D: BioGrid_Yeast, YeastLow |
| RPSA | 3921 | PSMD11 | 5717 | pp | -- | int.I2D: IntAct_Yeast |
| RPA2 | 6118 | TP53 | 7157 | pp | -- | int.Transfac: - |
| TP53 | 7157 | EIF2S2 | 8894 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: HPRD, IntAct, BioGrid, MINT, StelzlHigh; int.Mint: MI:0915(physical association); int.HPRD: yeast 2-hybrid |
| RPS3A | 6189 | PSMD6 | 9861 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: IntAct |
| ACO2 | 50 | PSMD11 | 5717 | pp | -- | int.I2D: YeastLow |
| ACTB | 60 | PSMD3 | 5709 | pp | -- | int.I2D: BioGrid_Yeast |
| PSMA1 | 5682 | PSMD6 | 9861 | pd | < | reg.ITFP.txt: no annot |
| PSMA1 | 5682 | PSMD6 | 9861 | pp | -- | int.Proteinpedia: Mass spectrometry; int.Intact: MI:0915(physical association); int.I2D: BioGrid_Yeast, IntAct, YeastMedium |
| RPSA | 3921 | VARS | 7407 | pp | -- | int.I2D: IntAct_Yeast |
| PSMD3 | 5709 | PSMD11 | 5717 | pp | -- | int.I2D: BioGrid_Yeast, IntAct_Yeast, Krogan_Core, MINT_Yeast, YeastHigh, INTEROLOG |
| PSMD1 | 5707 | PSMD11 | 5717 | pp | -- | int.I2D: BioGrid_Yeast, IntAct_Yeast, Krogan_Core, MINT_Yeast |
| ATP6V1B2 | 526 | CLTC | 1213 | pp | -- | int.I2D: IntAct_Yeast |
| ACTB | 60 | EEF2 | 1938 | pp | -- | int.I2D: YeastLow, IntAct_Yeast |
| ACTB | 60 | RBX1 | 9978 | pp | -- | int.I2D: BioGrid_Yeast |
| PSMD11 | 5717 | TP53 | 7157 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: BioGrid, MINT, StelzlHigh, HPRD, IntAct; int.Mint: MI:0915(physical association); int.HPRD: yeast 2-hybrid |
| GSK3B | 2932 | TUBG1 | 7283 | pp | -- | int.I2D: MINT |
| PSMA1 | 5682 | PSMA2 | 5683 | pp | -- | int.Intact: MI:0915(physical association), MI:0914(association); int.I2D: BioGrid_Worm, BioGrid_Yeast, BIND_Worm, CE_DATA, HPRD, IntAct, IntAct_Mouse, IntAct_Yeast, INTEROLOG, MINT_Worm, BioGrid, IntAct_Fly, IntAct_Worm, Krogan_Core, MINT_Yeast, YeastHigh; int.HPRD: yeast 2-hybrid |
| ACTB | 60 | RPSA | 3921 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: IntAct_Yeast, IntAct |
| CLTC | 1213 | EIF2S2 | 8894 | pp | -- | int.I2D: YeastLow |
| TUBG1 | 7283 | VARS | 7407 | pd | < | reg.ITFP.txt: no annot |
| PSMA2 | 5683 | PSMA6 | 5687 | pp | -- | int.Intact: MI:0914(association), MI:0915(physical association); int.I2D: BCI, BioGrid, BioGrid_Yeast, BIND_Yeast, IntAct, IntAct_Yeast, INTEROLOG, MINT_Yeast, YeastHigh, HPRD, Krogan_Core, Tarassov_PCA, Yu_GoldStd; int.HPRD: yeast 2-hybrid |
| ATP6V1B2 | 526 | CHKB | 1120 | pp | -- | int.I2D: IntAct_Yeast |
| EEF2 | 1938 | TP53 | 7157 | pp | -- | int.I2D: BioGrid, HPRD, BCI; int.HPRD: in vivo |
| CHKB | 1120 | PSMD3 | 5709 | pp | -- | int.I2D: IntAct_Yeast |
| CHKB | 1120 | GSK3B | 2932 | pp | -- | int.I2D: BioGrid_Yeast, IntAct_Yeast, MINT_Yeast, YeastLow |
| SGK1 | 6446 | VARS | 7407 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: IntAct |
| EEF2 | 1938 | RAD23B | 5887 | pp | -- | int.I2D: Krogan_NonCore |
| RPS3A | 6189 | SAP18 | 10284 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: IntAct, BioGrid, HPRD, MINT; int.Mint: MI:0915(physical association); int.HPRD: yeast 2-hybrid |
| PSMA1 | 5682 | PSMB7 | 5695 | pp | -- | int.Intact: MI:0914(association); int.I2D: BioGrid_Yeast, IntAct, IntAct_Mouse, IntAct_Yeast, YeastLow, Krogan_Core, MINT_Yeast |
| RAD23B | 5887 | RPS3A | 6189 | pp | -- | int.I2D: BIND_Yeast, MINT_Yeast, MIPS, IntAct_Yeast, YeastLow |
| RPS3A | 6189 | RPL14 | 9045 | pp | -- | int.I2D: BioGrid_Yeast |
| ACTB | 60 | PSMA1 | 5682 | pp | -- | int.I2D: BioGrid_Yeast |
| EEF2 | 1938 | PSMD3 | 5709 | pp | -- | int.I2D: Krogan_NonCore |
| PSMA6 | 5687 | PSMD1 | 5707 | pp | -- | int.I2D: BioGrid_Yeast, IntAct_Yeast |
| PSMB7 | 5695 | RBX1 | 9978 | pd | < | reg.ITFP.txt: no annot |
| ACTB | 60 | ERBB2 | 2064 | pp | -- | int.Intact: MI:0915(physical association), MI:0403(colocalization), MI:0914(association) |
| PGD | 5226 | PSMD11 | 5717 | pp | -- | int.I2D: YeastLow |
| PSMD3 | 5709 | TUBG1 | 7283 | pd | > | reg.ITFP.txt: no annot |
| PSMB7 | 5695 | PSMD11 | 5717 | pp | -- | int.I2D: BioGrid_Yeast |
| KPNB1 | 3837 | PSMA2 | 5683 | pp | -- | int.I2D: Krogan_NonCore, YeastLow |
| ATP6V1B2 | 526 | CDC16 | 8881 | pp | -- | int.I2D: IntAct_Yeast |
| PSMD1 | 5707 | PSMD6 | 9861 | pp | -- | int.Proteinpedia: Mass spectrometry; int.Intact: MI:0915(physical association); int.I2D: BioGrid, BioGrid_Yeast, IntAct_Yeast, MINT_Yeast, IntAct, Krogan_Core |
| ACTB | 60 | PSMD11 | 5717 | pp | -- | int.I2D: BioGrid_Yeast |
| CLTC | 1213 | PFN1 | 5216 | pp | -- | int.I2D: BioGrid_Mouse |
| PGD | 5226 | PSMD3 | 5709 | pp | -- | int.I2D: YeastLow |
| PSMA6 | 5687 | PSMD3 | 5709 | pp | -- | int.I2D: BioGrid_Yeast, YeastLow |
| PSMD3 | 5709 | PSMD6 | 9861 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: BioGrid_Worm, BioGrid_Yeast, BIND_Worm, CE_DATA, IntAct, IntAct_Yeast, MINT_Worm, MINT_Yeast, YeastHigh, BioGrid, BIND_Yeast, IntAct_Worm, INTEROLOG, Krogan_Core, MIPS |
| CLTC | 1213 | KPNB1 | 3837 | pp | -- | int.Intact: MI:0914(association) |
| ACO2 | 50 | KPNB1 | 3837 | pp | -- | int.I2D: IntAct_Yeast |
| RPS3A | 6189 | RPS11 | 6205 | pp | -- | int.I2D: BioGrid_Yeast |
| PTGS2 | 5743 | RBX1 | 9978 | pp | -- | int.I2D: BioGrid |
| ACTB | 60 | PSMD6 | 9861 | pp | -- | int.I2D: BioGrid_Yeast |
| RPS11 | 6205 | RPL14 | 9045 | pp | -- | int.I2D: BioGrid_Yeast |
| ERBB2 | 2064 | KPNB1 | 3837 | pp | -- | int.Intact: MI:0915(physical association), MI:0914(association), MI:0403(colocalization) |
| PSMD3 | 5709 | VARS | 7407 | pd | <> | reg.ITFP.txt: no annot |
| ACTB | 60 | PSMA6 | 5687 | pp | -- | int.I2D: BioGrid_Yeast |
| PSMB7 | 5695 | PSMD1 | 5707 | pp | -- | int.Intact: MI:0914(association); int.I2D: BioGrid_Yeast, IntAct |
| PSMA2 | 5683 | PSMD3 | 5709 | pp | -- | int.I2D: BioGrid_Yeast, YeastLow |
| PSMA1 | 5682 | PSMA6 | 5687 | pp | -- | int.Intact: MI:0914(association), MI:0915(physical association); int.I2D: BioGrid_Worm, BioGrid_Yeast, BIND_Worm, CE_DATA, IntAct, IntAct_Mouse, IntAct_Yeast, INTEROLOG, MINT_Worm, YeastHigh, IntAct_Worm, Krogan_Core, MINT_Yeast; int.Mint: MI:0914(association) |
| ACO2 | 50 | ISYNA1 | 51477 | pp | -- | int.I2D: BioGrid_Yeast |
| PSMD11 | 5717 | TUBG1 | 7283 | pd | > | reg.ITFP.txt: no annot |
| PSMA6 | 5687 | SGK1 | 6446 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: IntAct |
| PSMA1 | 5682 | PSMD1 | 5707 | pp | -- | int.I2D: BioGrid_Yeast |
| ACTB | 60 | PSMB7 | 5695 | pp | -- | int.I2D: BioGrid_Yeast |
| ACTB | 60 | RAD23B | 5887 | pp | -- | int.I2D: IntAct_Rat |
| ACTB | 60 | RPA2 | 6118 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: IntAct |
| PSMB7 | 5695 | PSMD6 | 9861 | pd | < | reg.ITFP.txt: no annot |
| PSMB7 | 5695 | PSMD6 | 9861 | pp | -- | int.Proteinpedia: Mass spectrometry; int.Intact: MI:0915(physical association); int.I2D: BioGrid_Yeast, IntAct |
| ACTB | 60 | PFN1 | 5216 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: BioGrid, BioGrid_Mouse, HPRD, MINT_Mouse, BCI, IntAct; int.HPRD: in vitro; int.DIP: MI:0407(direct interaction) |
| PSMD11 | 5717 | EFTUD2 | 9343 | pd | > | reg.ITFP.txt: no annot |
| KPNB1 | 3837 | PSMA1 | 5682 | pp | -- | int.I2D: YeastLow |
| ACO2 | 50 | PGD | 5226 | pp | -- | int.I2D: YeastLow |
| ATP6V1B2 | 526 | RPSA | 3921 | pp | -- | int.I2D: IntAct_Yeast |
| ACTB | 60 | CDC16 | 8881 | pp | -- | int.I2D: YeastLow |
| PSMD1 | 5707 | PTGS2 | 5743 | pp | -- | int.I2D: BioGrid, INNATEDB |
| ACTB | 60 | RPS3A | 6189 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: IntAct |
| PSMA1 | 5682 | PSMD11 | 5717 | pp | -- | int.I2D: BioGrid_Yeast, YeastLow |
| RPS3A | 6189 | SGK1 | 6446 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: IntAct |
| PSMA6 | 5687 | PSMB7 | 5695 | pp | -- | int.I2D: BioGrid_Yeast, BIND_Yeast, Krogan_Core, MINT_Yeast, YeastLow |
| GSK3B | 2932 | EFTUD2 | 9343 | pp | -- | int.I2D: BioGrid, MINT; int.Mint: MI:0915(physical association) |
| ERBB2 | 2064 | ITK | 3702 | pp | -- | int.I2D: JonesErbB1, MINT; int.Mint: MI:0407(direct interaction) |
| KPNB1 | 3837 | PSMA6 | 5687 | pp | -- | int.I2D: YeastLow |
| PSMA2 | 5683 | PSMD6 | 9861 | pp | -- | int.Proteinpedia: Mass spectrometry; int.Intact: MI:0915(physical association); int.I2D: BioGrid_Yeast, IntAct, YeastLow, BioGrid |
| PSMA6 | 5687 | PSMD6 | 9861 | pp | -- | int.Proteinpedia: Mass spectrometry; int.Intact: MI:0915(physical association); int.I2D: BioGrid_Yeast, IntAct, YeastLow |
| PSMA6 | 5687 | RAD23B | 5887 | pp | -- | int.I2D: Krogan_NonCore |
| ACTB | 60 | ATP6V1B2 | 526 | pp | -- | int.I2D: BioGrid_Yeast |
| CLTC | 1213 | ISYNA1 | 51477 | pp | -- | int.I2D: BioGrid_Yeast, MINT_Yeast, Tarassov_PCA, IntAct_Yeast |
| KPNB1 | 3837 | PSMD11 | 5717 | pp | -- | int.I2D: Krogan_NonCore |
| RPSA | 3921 | RPS11 | 6205 | pp | -- | int.I2D: BioGrid_Yeast, IntAct_Yeast |
| PSMA1 | 5682 | PSMD3 | 5709 | pp | -- | int.I2D: BioGrid_Yeast, YeastMedium |
| PSMA6 | 5687 | PSMD11 | 5717 | pp | -- | int.I2D: BioGrid_Yeast, YeastLow |
| PSMD11 | 5717 | EIF2S2 | 8894 | pd | > | reg.ITFP.txt: no annot |
| CLTC | 1213 | ERBB2 | 2064 | pp | -- | int.Intact: MI:0914(association) |
Related GO terms (632)
| Accession number | Name | Hypergeometric test | Corrected p-value | Enrichment ratio | Occurrence in subnetwork | Occurrences in all snw genes | Occurrences in all int/reg genes |
|---|---|---|---|---|---|---|---|
| GO:0005829 | cytosol | 2.14e-18 | 3.49e-14 | 2.369 | 30 | 125 | 2562 |
| GO:0000502 | proteasome complex | 5.44e-15 | 8.87e-11 | 6.097 | 9 | 22 | 58 |
| GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest | 1.61e-14 | 2.63e-10 | 5.933 | 9 | 22 | 65 |
| GO:0051436 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 1.61e-14 | 2.63e-10 | 5.933 | 9 | 24 | 65 |
| GO:0051437 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 3.26e-14 | 5.32e-10 | 5.826 | 9 | 24 | 70 |
| GO:0016071 | mRNA metabolic process | 4.32e-14 | 7.04e-10 | 4.569 | 12 | 34 | 223 |
| GO:0051439 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 5.50e-14 | 8.98e-10 | 5.745 | 9 | 24 | 74 |
| GO:0031145 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process | 1.02e-13 | 1.66e-09 | 5.651 | 9 | 25 | 79 |
| GO:0016070 | RNA metabolic process | 1.46e-13 | 2.39e-09 | 4.422 | 12 | 34 | 247 |
| GO:0006521 | regulation of cellular amino acid metabolic process | 1.56e-13 | 2.54e-09 | 6.141 | 8 | 21 | 50 |
| GO:0016032 | viral process | 2.46e-13 | 4.02e-09 | 3.615 | 15 | 55 | 540 |
| GO:0010467 | gene expression | 3.07e-13 | 5.01e-09 | 3.399 | 16 | 58 | 669 |
| GO:0042981 | regulation of apoptotic process | 9.57e-13 | 1.56e-08 | 4.869 | 10 | 26 | 151 |
| GO:0002479 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent | 3.76e-12 | 6.13e-08 | 5.595 | 8 | 23 | 73 |
| GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I | 5.84e-12 | 9.54e-08 | 5.518 | 8 | 23 | 77 |
| GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I | 3.01e-11 | 4.91e-07 | 5.230 | 8 | 23 | 94 |
| GO:0000082 | G1/S transition of mitotic cell cycle | 3.67e-11 | 5.99e-07 | 4.726 | 9 | 33 | 150 |
| GO:0000209 | protein polyubiquitination | 1.66e-10 | 2.71e-06 | 4.927 | 8 | 21 | 116 |
| GO:0005654 | nucleoplasm | 5.09e-10 | 8.30e-06 | 2.688 | 16 | 83 | 1095 |
| GO:0000278 | mitotic cell cycle | 7.65e-10 | 1.25e-05 | 3.608 | 11 | 52 | 398 |
| GO:0043066 | negative regulation of apoptotic process | 1.85e-09 | 3.03e-05 | 3.486 | 11 | 30 | 433 |
| GO:0034641 | cellular nitrogen compound metabolic process | 4.82e-09 | 7.87e-05 | 4.317 | 8 | 25 | 177 |
| GO:0006915 | apoptotic process | 3.26e-08 | 5.33e-04 | 3.087 | 11 | 34 | 571 |
| GO:0022624 | proteasome accessory complex | 5.21e-08 | 8.50e-04 | 6.698 | 4 | 9 | 17 |
| GO:0005839 | proteasome core complex | 6.68e-08 | 1.09e-03 | 6.615 | 4 | 11 | 18 |
| GO:0004298 | threonine-type endopeptidase activity | 1.06e-07 | 1.72e-03 | 6.463 | 4 | 11 | 20 |
| GO:0070062 | extracellular vesicular exosome | 3.71e-07 | 6.05e-03 | 1.736 | 19 | 98 | 2516 |
| GO:0044281 | small molecule metabolic process | 3.92e-07 | 6.40e-03 | 2.254 | 14 | 57 | 1295 |
| GO:0019773 | proteasome core complex, alpha-subunit complex | 5.96e-07 | 9.73e-03 | 7.370 | 3 | 5 | 8 |
| GO:0006414 | translational elongation | 2.03e-06 | 3.32e-02 | 4.568 | 5 | 11 | 93 |
| GO:0005838 | proteasome regulatory particle | 2.33e-06 | 3.80e-02 | 6.785 | 3 | 7 | 12 |
| GO:0019058 | viral life cycle | 5.79e-06 | 9.46e-02 | 4.261 | 5 | 10 | 115 |
| GO:0006413 | translational initiation | 1.09e-05 | 1.79e-01 | 4.073 | 5 | 12 | 131 |
| GO:0006412 | translation | 1.34e-05 | 2.18e-01 | 3.493 | 6 | 15 | 235 |
| GO:0044822 | poly(A) RNA binding | 1.72e-05 | 2.81e-01 | 2.170 | 11 | 50 | 1078 |
| GO:0005844 | polysome | 2.38e-05 | 3.89e-01 | 5.726 | 3 | 4 | 25 |
| GO:0019083 | viral transcription | 3.28e-05 | 5.36e-01 | 4.445 | 4 | 8 | 81 |
| GO:0006415 | translational termination | 4.35e-05 | 7.10e-01 | 4.342 | 4 | 8 | 87 |
| GO:0005515 | protein binding | 5.36e-05 | 8.75e-01 | 0.904 | 26 | 172 | 6127 |
| GO:0006614 | SRP-dependent cotranslational protein targeting to membrane | 8.74e-05 | 1.00e+00 | 4.085 | 4 | 8 | 104 |
| GO:0022627 | cytosolic small ribosomal subunit | 9.27e-05 | 1.00e+00 | 5.085 | 3 | 3 | 39 |
| GO:0044267 | cellular protein metabolic process | 1.06e-04 | 1.00e+00 | 2.641 | 7 | 24 | 495 |
| GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay | 1.25e-04 | 1.00e+00 | 3.952 | 4 | 10 | 114 |
| GO:0030529 | ribonucleoprotein complex | 1.25e-04 | 1.00e+00 | 3.952 | 4 | 8 | 114 |
| GO:0005634 | nucleus | 1.50e-04 | 1.00e+00 | 1.007 | 22 | 131 | 4828 |
| GO:0006983 | ER overload response | 1.78e-04 | 1.00e+00 | 6.615 | 2 | 2 | 9 |
| GO:0003684 | damaged DNA binding | 2.07e-04 | 1.00e+00 | 4.698 | 3 | 11 | 51 |
| GO:0010226 | response to lithium ion | 2.22e-04 | 1.00e+00 | 6.463 | 2 | 2 | 10 |
| GO:0031571 | mitotic G1 DNA damage checkpoint | 2.72e-04 | 1.00e+00 | 6.326 | 2 | 3 | 11 |
| GO:0003735 | structural constituent of ribosome | 2.83e-04 | 1.00e+00 | 3.645 | 4 | 8 | 141 |
| GO:0016020 | membrane | 3.11e-04 | 1.00e+00 | 1.600 | 12 | 80 | 1746 |
| GO:0032886 | regulation of microtubule-based process | 3.25e-04 | 1.00e+00 | 6.200 | 2 | 4 | 12 |
| GO:0030234 | enzyme regulator activity | 3.84e-04 | 1.00e+00 | 6.085 | 2 | 3 | 13 |
| GO:0019903 | protein phosphatase binding | 3.88e-04 | 1.00e+00 | 4.393 | 3 | 4 | 63 |
| GO:0006289 | nucleotide-excision repair | 5.07e-04 | 1.00e+00 | 4.261 | 3 | 12 | 69 |
| GO:0042176 | regulation of protein catabolic process | 5.88e-04 | 1.00e+00 | 5.785 | 2 | 3 | 16 |
| GO:0031625 | ubiquitin protein ligase binding | 7.11e-04 | 1.00e+00 | 3.293 | 4 | 13 | 180 |
| GO:0019901 | protein kinase binding | 7.31e-04 | 1.00e+00 | 2.785 | 5 | 21 | 320 |
| GO:0005730 | nucleolus | 9.22e-04 | 1.00e+00 | 1.527 | 11 | 70 | 1684 |
| GO:0000718 | nucleotide-excision repair, DNA damage removal | 1.02e-03 | 1.00e+00 | 5.393 | 2 | 5 | 21 |
| GO:0003723 | RNA binding | 1.16e-03 | 1.00e+00 | 2.635 | 5 | 19 | 355 |
| GO:0000060 | protein import into nucleus, translocation | 1.34e-03 | 1.00e+00 | 5.200 | 2 | 4 | 24 |
| GO:0005925 | focal adhesion | 1.40e-03 | 1.00e+00 | 2.576 | 5 | 18 | 370 |
| GO:0071456 | cellular response to hypoxia | 1.41e-03 | 1.00e+00 | 3.755 | 3 | 4 | 98 |
| GO:0051059 | NF-kappaB binding | 1.45e-03 | 1.00e+00 | 5.141 | 2 | 3 | 25 |
| GO:0090271 | positive regulation of fibroblast growth factor production | 2.27e-03 | 1.00e+00 | 8.785 | 1 | 1 | 1 |
| GO:0001042 | RNA polymerase I core binding | 2.27e-03 | 1.00e+00 | 8.785 | 1 | 1 | 1 |
| GO:0090362 | positive regulation of platelet-derived growth factor production | 2.27e-03 | 1.00e+00 | 8.785 | 1 | 1 | 1 |
| GO:0035639 | purine ribonucleoside triphosphate binding | 2.27e-03 | 1.00e+00 | 8.785 | 1 | 1 | 1 |
| GO:0019521 | D-gluconate metabolic process | 2.27e-03 | 1.00e+00 | 8.785 | 1 | 1 | 1 |
| GO:0004512 | inositol-3-phosphate synthase activity | 2.27e-03 | 1.00e+00 | 8.785 | 1 | 1 | 1 |
| GO:0060453 | regulation of gastric acid secretion | 2.27e-03 | 1.00e+00 | 8.785 | 1 | 1 | 1 |
| GO:0035633 | maintenance of blood-brain barrier | 2.27e-03 | 1.00e+00 | 8.785 | 1 | 1 | 1 |
| GO:0034644 | cellular response to UV | 2.38e-03 | 1.00e+00 | 4.785 | 2 | 5 | 32 |
| GO:0033572 | transferrin transport | 2.38e-03 | 1.00e+00 | 4.785 | 2 | 6 | 32 |
| GO:0001085 | RNA polymerase II transcription factor binding | 2.68e-03 | 1.00e+00 | 4.698 | 2 | 2 | 34 |
| GO:0005524 | ATP binding | 2.68e-03 | 1.00e+00 | 1.552 | 9 | 46 | 1354 |
| GO:0005737 | cytoplasm | 3.37e-03 | 1.00e+00 | 0.915 | 17 | 98 | 3976 |
| GO:0006284 | base-excision repair | 3.51e-03 | 1.00e+00 | 4.500 | 2 | 7 | 39 |
| GO:0019899 | enzyme binding | 3.97e-03 | 1.00e+00 | 2.615 | 4 | 11 | 288 |
| GO:0051054 | positive regulation of DNA metabolic process | 4.53e-03 | 1.00e+00 | 7.785 | 1 | 1 | 2 |
| GO:0097252 | oligodendrocyte apoptotic process | 4.53e-03 | 1.00e+00 | 7.785 | 1 | 1 | 2 |
| GO:0003994 | aconitate hydratase activity | 4.53e-03 | 1.00e+00 | 7.785 | 1 | 1 | 2 |
| GO:0006407 | rRNA export from nucleus | 4.53e-03 | 1.00e+00 | 7.785 | 1 | 1 | 2 |
| GO:0071109 | superior temporal gyrus development | 4.53e-03 | 1.00e+00 | 7.785 | 1 | 1 | 2 |
| GO:2000077 | negative regulation of type B pancreatic cell development | 4.53e-03 | 1.00e+00 | 7.785 | 1 | 1 | 2 |
| GO:0090343 | positive regulation of cell aging | 4.53e-03 | 1.00e+00 | 7.785 | 1 | 1 | 2 |
| GO:0000461 | endonucleolytic cleavage to generate mature 3'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 4.53e-03 | 1.00e+00 | 7.785 | 1 | 1 | 2 |
| GO:0019322 | pentose biosynthetic process | 4.53e-03 | 1.00e+00 | 7.785 | 1 | 1 | 2 |
| GO:0004832 | valine-tRNA ligase activity | 4.53e-03 | 1.00e+00 | 7.785 | 1 | 1 | 2 |
| GO:0032227 | negative regulation of synaptic transmission, dopaminergic | 4.53e-03 | 1.00e+00 | 7.785 | 1 | 1 | 2 |
| GO:0051538 | 3 iron, 4 sulfur cluster binding | 4.53e-03 | 1.00e+00 | 7.785 | 1 | 1 | 2 |
| GO:0044337 | canonical Wnt signaling pathway involved in positive regulation of apoptotic process | 4.53e-03 | 1.00e+00 | 7.785 | 1 | 2 | 2 |
| GO:1901525 | negative regulation of macromitophagy | 4.53e-03 | 1.00e+00 | 7.785 | 1 | 1 | 2 |
| GO:0002176 | male germ cell proliferation | 4.53e-03 | 1.00e+00 | 7.785 | 1 | 1 | 2 |
| GO:0004103 | choline kinase activity | 4.53e-03 | 1.00e+00 | 7.785 | 1 | 1 | 2 |
| GO:0000715 | nucleotide-excision repair, DNA damage recognition | 4.53e-03 | 1.00e+00 | 7.785 | 1 | 1 | 2 |
| GO:0006438 | valyl-tRNA aminoacylation | 4.53e-03 | 1.00e+00 | 7.785 | 1 | 1 | 2 |
| GO:0032633 | interleukin-4 production | 4.53e-03 | 1.00e+00 | 7.785 | 1 | 1 | 2 |
| GO:0005055 | laminin receptor activity | 4.53e-03 | 1.00e+00 | 7.785 | 1 | 1 | 2 |
| GO:0001865 | NK T cell differentiation | 4.53e-03 | 1.00e+00 | 7.785 | 1 | 1 | 2 |
| GO:0004666 | prostaglandin-endoperoxide synthase activity | 4.53e-03 | 1.00e+00 | 7.785 | 1 | 1 | 2 |
| GO:0043234 | protein complex | 4.58e-03 | 1.00e+00 | 2.556 | 4 | 17 | 300 |
| GO:0045727 | positive regulation of translation | 4.86e-03 | 1.00e+00 | 4.261 | 2 | 4 | 46 |
| GO:0050727 | regulation of inflammatory response | 5.07e-03 | 1.00e+00 | 4.230 | 2 | 3 | 47 |
| GO:0038095 | Fc-epsilon receptor signaling pathway | 6.76e-03 | 1.00e+00 | 2.952 | 3 | 7 | 171 |
| GO:0061574 | ASAP complex | 6.79e-03 | 1.00e+00 | 7.200 | 1 | 1 | 3 |
| GO:0014043 | negative regulation of neuron maturation | 6.79e-03 | 1.00e+00 | 7.200 | 1 | 1 | 3 |
| GO:0000320 | re-entry into mitotic cell cycle | 6.79e-03 | 1.00e+00 | 7.200 | 1 | 1 | 3 |
| GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity | 6.79e-03 | 1.00e+00 | 7.200 | 1 | 1 | 3 |
| GO:2000466 | negative regulation of glycogen (starch) synthase activity | 6.79e-03 | 1.00e+00 | 7.200 | 1 | 1 | 3 |
| GO:1900126 | negative regulation of hyaluronan biosynthetic process | 6.79e-03 | 1.00e+00 | 7.200 | 1 | 1 | 3 |
| GO:0035033 | histone deacetylase regulator activity | 6.79e-03 | 1.00e+00 | 7.200 | 1 | 1 | 3 |
| GO:0006021 | inositol biosynthetic process | 6.79e-03 | 1.00e+00 | 7.200 | 1 | 1 | 3 |
| GO:0002360 | T cell lineage commitment | 6.79e-03 | 1.00e+00 | 7.200 | 1 | 1 | 3 |
| GO:0009051 | pentose-phosphate shunt, oxidative branch | 6.79e-03 | 1.00e+00 | 7.200 | 1 | 1 | 3 |
| GO:0034103 | regulation of tissue remodeling | 6.79e-03 | 1.00e+00 | 7.200 | 1 | 1 | 3 |
| GO:0071942 | XPC complex | 6.79e-03 | 1.00e+00 | 7.200 | 1 | 1 | 3 |
| GO:0009750 | response to fructose | 6.79e-03 | 1.00e+00 | 7.200 | 1 | 1 | 3 |
| GO:0035794 | positive regulation of mitochondrial membrane permeability | 6.79e-03 | 1.00e+00 | 7.200 | 1 | 1 | 3 |
| GO:0051097 | negative regulation of helicase activity | 6.79e-03 | 1.00e+00 | 7.200 | 1 | 1 | 3 |
| GO:0005850 | eukaryotic translation initiation factor 2 complex | 6.79e-03 | 1.00e+00 | 7.200 | 1 | 1 | 3 |
| GO:0044027 | hypermethylation of CpG island | 6.79e-03 | 1.00e+00 | 7.200 | 1 | 1 | 3 |
| GO:0090336 | positive regulation of brown fat cell differentiation | 6.79e-03 | 1.00e+00 | 7.200 | 1 | 1 | 3 |
| GO:0071439 | clathrin complex | 6.79e-03 | 1.00e+00 | 7.200 | 1 | 1 | 3 |
| GO:0050473 | arachidonate 15-lipoxygenase activity | 6.79e-03 | 1.00e+00 | 7.200 | 1 | 1 | 3 |
| GO:0002039 | p53 binding | 6.89e-03 | 1.00e+00 | 4.004 | 2 | 7 | 55 |
| GO:0005813 | centrosome | 7.04e-03 | 1.00e+00 | 2.380 | 4 | 12 | 339 |
| GO:0000932 | cytoplasmic mRNA processing body | 7.13e-03 | 1.00e+00 | 3.978 | 2 | 3 | 56 |
| GO:0008217 | regulation of blood pressure | 7.63e-03 | 1.00e+00 | 3.927 | 2 | 5 | 58 |
| GO:0006302 | double-strand break repair | 8.68e-03 | 1.00e+00 | 3.831 | 2 | 8 | 62 |
| GO:0030686 | 90S preribosome | 9.04e-03 | 1.00e+00 | 6.785 | 1 | 1 | 4 |
| GO:0070294 | renal sodium ion absorption | 9.04e-03 | 1.00e+00 | 6.785 | 1 | 1 | 4 |
| GO:0004305 | ethanolamine kinase activity | 9.04e-03 | 1.00e+00 | 6.785 | 1 | 1 | 4 |
| GO:0019788 | NEDD8 ligase activity | 9.04e-03 | 1.00e+00 | 6.785 | 1 | 1 | 4 |
| GO:0043125 | ErbB-3 class receptor binding | 9.04e-03 | 1.00e+00 | 6.785 | 1 | 1 | 4 |
| GO:0002326 | B cell lineage commitment | 9.04e-03 | 1.00e+00 | 6.785 | 1 | 1 | 4 |
| GO:0051534 | negative regulation of NFAT protein import into nucleus | 9.04e-03 | 1.00e+00 | 6.785 | 1 | 1 | 4 |
| GO:0033088 | negative regulation of immature T cell proliferation in thymus | 9.04e-03 | 1.00e+00 | 6.785 | 1 | 1 | 4 |
| GO:0032232 | negative regulation of actin filament bundle assembly | 9.04e-03 | 1.00e+00 | 6.785 | 1 | 1 | 4 |
| GO:0071782 | endoplasmic reticulum tubular network | 9.04e-03 | 1.00e+00 | 6.785 | 1 | 1 | 4 |
| GO:0000774 | adenyl-nucleotide exchange factor activity | 9.04e-03 | 1.00e+00 | 6.785 | 1 | 1 | 4 |
| GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 9.04e-03 | 1.00e+00 | 6.785 | 1 | 1 | 4 |
| GO:0000212 | meiotic spindle organization | 9.04e-03 | 1.00e+00 | 6.785 | 1 | 1 | 4 |
| GO:0032051 | clathrin light chain binding | 9.04e-03 | 1.00e+00 | 6.785 | 1 | 1 | 4 |
| GO:0090403 | oxidative stress-induced premature senescence | 9.04e-03 | 1.00e+00 | 6.785 | 1 | 1 | 4 |
| GO:0031467 | Cul7-RING ubiquitin ligase complex | 9.04e-03 | 1.00e+00 | 6.785 | 1 | 1 | 4 |
| GO:0006610 | ribosomal protein import into nucleus | 9.04e-03 | 1.00e+00 | 6.785 | 1 | 1 | 4 |
| GO:1903077 | negative regulation of protein localization to plasma membrane | 9.04e-03 | 1.00e+00 | 6.785 | 1 | 1 | 4 |
| GO:0071260 | cellular response to mechanical stimulus | 9.79e-03 | 1.00e+00 | 3.741 | 2 | 4 | 66 |
| GO:0003697 | single-stranded DNA binding | 1.07e-02 | 1.00e+00 | 3.676 | 2 | 9 | 69 |
| GO:0003924 | GTPase activity | 1.08e-02 | 1.00e+00 | 2.705 | 3 | 9 | 203 |
| GO:1900029 | positive regulation of ruffle assembly | 1.13e-02 | 1.00e+00 | 6.463 | 1 | 1 | 5 |
| GO:0031622 | positive regulation of fever generation | 1.13e-02 | 1.00e+00 | 6.463 | 1 | 2 | 5 |
| GO:2000001 | regulation of DNA damage checkpoint | 1.13e-02 | 1.00e+00 | 6.463 | 1 | 1 | 5 |
| GO:0045986 | negative regulation of smooth muscle contraction | 1.13e-02 | 1.00e+00 | 6.463 | 1 | 1 | 5 |
| GO:0043248 | proteasome assembly | 1.13e-02 | 1.00e+00 | 6.463 | 1 | 1 | 5 |
| GO:0036016 | cellular response to interleukin-3 | 1.13e-02 | 1.00e+00 | 6.463 | 1 | 1 | 5 |
| GO:0030891 | VCB complex | 1.13e-02 | 1.00e+00 | 6.463 | 1 | 2 | 5 |
| GO:0017081 | chloride channel regulator activity | 1.13e-02 | 1.00e+00 | 6.463 | 1 | 1 | 5 |
| GO:0005827 | polar microtubule | 1.13e-02 | 1.00e+00 | 6.463 | 1 | 1 | 5 |
| GO:0032411 | positive regulation of transporter activity | 1.13e-02 | 1.00e+00 | 6.463 | 1 | 1 | 5 |
| GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex | 1.13e-02 | 1.00e+00 | 6.463 | 1 | 2 | 5 |
| GO:0071636 | positive regulation of transforming growth factor beta production | 1.13e-02 | 1.00e+00 | 6.463 | 1 | 1 | 5 |
| GO:0097371 | MDM2/MDM4 family protein binding | 1.13e-02 | 1.00e+00 | 6.463 | 1 | 1 | 5 |
| GO:0031461 | cullin-RING ubiquitin ligase complex | 1.13e-02 | 1.00e+00 | 6.463 | 1 | 1 | 5 |
| GO:0031915 | positive regulation of synaptic plasticity | 1.13e-02 | 1.00e+00 | 6.463 | 1 | 1 | 5 |
| GO:2000738 | positive regulation of stem cell differentiation | 1.13e-02 | 1.00e+00 | 6.463 | 1 | 1 | 5 |
| GO:0006102 | isocitrate metabolic process | 1.13e-02 | 1.00e+00 | 6.463 | 1 | 1 | 5 |
| GO:0000730 | DNA recombinase assembly | 1.13e-02 | 1.00e+00 | 6.463 | 1 | 3 | 5 |
| GO:0031394 | positive regulation of prostaglandin biosynthetic process | 1.13e-02 | 1.00e+00 | 6.463 | 1 | 1 | 5 |
| GO:0043161 | proteasome-mediated ubiquitin-dependent protein catabolic process | 1.28e-02 | 1.00e+00 | 3.537 | 2 | 3 | 76 |
| GO:0006184 | GTP catabolic process | 1.34e-02 | 1.00e+00 | 2.589 | 3 | 9 | 220 |
| GO:0010666 | positive regulation of cardiac muscle cell apoptotic process | 1.35e-02 | 1.00e+00 | 6.200 | 1 | 1 | 6 |
| GO:1902108 | regulation of mitochondrial membrane permeability involved in apoptotic process | 1.35e-02 | 1.00e+00 | 6.200 | 1 | 1 | 6 |
| GO:0002309 | T cell proliferation involved in immune response | 1.35e-02 | 1.00e+00 | 6.200 | 1 | 1 | 6 |
| GO:0006101 | citrate metabolic process | 1.35e-02 | 1.00e+00 | 6.200 | 1 | 1 | 6 |
| GO:0030118 | clathrin coat | 1.35e-02 | 1.00e+00 | 6.200 | 1 | 1 | 6 |
| GO:0010042 | response to manganese ion | 1.35e-02 | 1.00e+00 | 6.200 | 1 | 1 | 6 |
| GO:0070245 | positive regulation of thymocyte apoptotic process | 1.35e-02 | 1.00e+00 | 6.200 | 1 | 1 | 6 |
| GO:0010614 | negative regulation of cardiac muscle hypertrophy | 1.35e-02 | 1.00e+00 | 6.200 | 1 | 1 | 6 |
| GO:0002181 | cytoplasmic translation | 1.35e-02 | 1.00e+00 | 6.200 | 1 | 1 | 6 |
| GO:0030130 | clathrin coat of trans-Golgi network vesicle | 1.35e-02 | 1.00e+00 | 6.200 | 1 | 1 | 6 |
| GO:0031466 | Cul5-RING ubiquitin ligase complex | 1.35e-02 | 1.00e+00 | 6.200 | 1 | 1 | 6 |
| GO:0050774 | negative regulation of dendrite morphogenesis | 1.35e-02 | 1.00e+00 | 6.200 | 1 | 1 | 6 |
| GO:0030957 | Tat protein binding | 1.35e-02 | 1.00e+00 | 6.200 | 1 | 4 | 6 |
| GO:0007406 | negative regulation of neuroblast proliferation | 1.35e-02 | 1.00e+00 | 6.200 | 1 | 1 | 6 |
| GO:0045943 | positive regulation of transcription from RNA polymerase I promoter | 1.35e-02 | 1.00e+00 | 6.200 | 1 | 1 | 6 |
| GO:0031462 | Cul2-RING ubiquitin ligase complex | 1.58e-02 | 1.00e+00 | 5.978 | 1 | 2 | 7 |
| GO:0000028 | ribosomal small subunit assembly | 1.58e-02 | 1.00e+00 | 5.978 | 1 | 1 | 7 |
| GO:0002161 | aminoacyl-tRNA editing activity | 1.58e-02 | 1.00e+00 | 5.978 | 1 | 2 | 7 |
| GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis | 1.58e-02 | 1.00e+00 | 5.978 | 1 | 1 | 7 |
| GO:0006657 | CDP-choline pathway | 1.58e-02 | 1.00e+00 | 5.978 | 1 | 1 | 7 |
| GO:0033180 | proton-transporting V-type ATPase, V1 domain | 1.58e-02 | 1.00e+00 | 5.978 | 1 | 2 | 7 |
| GO:0030132 | clathrin coat of coated pit | 1.58e-02 | 1.00e+00 | 5.978 | 1 | 1 | 7 |
| GO:0031497 | chromatin assembly | 1.58e-02 | 1.00e+00 | 5.978 | 1 | 1 | 7 |
| GO:0000930 | gamma-tubulin complex | 1.58e-02 | 1.00e+00 | 5.978 | 1 | 1 | 7 |
| GO:0047485 | protein N-terminus binding | 1.62e-02 | 1.00e+00 | 3.359 | 2 | 4 | 86 |
| GO:0000733 | DNA strand renaturation | 1.80e-02 | 1.00e+00 | 5.785 | 1 | 1 | 8 |
| GO:0045116 | protein neddylation | 1.80e-02 | 1.00e+00 | 5.785 | 1 | 2 | 8 |
| GO:0045719 | negative regulation of glycogen biosynthetic process | 1.80e-02 | 1.00e+00 | 5.785 | 1 | 1 | 8 |
| GO:0030728 | ovulation | 1.80e-02 | 1.00e+00 | 5.785 | 1 | 1 | 8 |
| GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex | 1.80e-02 | 1.00e+00 | 5.785 | 1 | 2 | 8 |
| GO:0070688 | MLL5-L complex | 1.80e-02 | 1.00e+00 | 5.785 | 1 | 1 | 8 |
| GO:1901030 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway | 1.80e-02 | 1.00e+00 | 5.785 | 1 | 1 | 8 |
| GO:0035372 | protein localization to microtubule | 1.80e-02 | 1.00e+00 | 5.785 | 1 | 1 | 8 |
| GO:0006928 | cellular component movement | 1.84e-02 | 1.00e+00 | 3.261 | 2 | 7 | 92 |
| GO:0016363 | nuclear matrix | 1.84e-02 | 1.00e+00 | 3.261 | 2 | 11 | 92 |
| GO:0016605 | PML body | 1.84e-02 | 1.00e+00 | 3.261 | 2 | 5 | 92 |
| GO:0042470 | melanosome | 1.84e-02 | 1.00e+00 | 3.261 | 2 | 10 | 92 |
| GO:0005200 | structural constituent of cytoskeleton | 1.88e-02 | 1.00e+00 | 3.246 | 2 | 7 | 93 |
| GO:0001649 | osteoblast differentiation | 1.96e-02 | 1.00e+00 | 3.215 | 2 | 6 | 95 |
| GO:0004716 | receptor signaling protein tyrosine kinase activity | 2.02e-02 | 1.00e+00 | 5.615 | 1 | 1 | 9 |
| GO:0032434 | regulation of proteasomal ubiquitin-dependent protein catabolic process | 2.02e-02 | 1.00e+00 | 5.615 | 1 | 1 | 9 |
| GO:0031065 | positive regulation of histone deacetylation | 2.02e-02 | 1.00e+00 | 5.615 | 1 | 1 | 9 |
| GO:0008139 | nuclear localization sequence binding | 2.02e-02 | 1.00e+00 | 5.615 | 1 | 2 | 9 |
| GO:0008494 | translation activator activity | 2.02e-02 | 1.00e+00 | 5.615 | 1 | 1 | 9 |
| GO:0048156 | tau protein binding | 2.02e-02 | 1.00e+00 | 5.615 | 1 | 1 | 9 |
| GO:0032609 | interferon-gamma production | 2.02e-02 | 1.00e+00 | 5.615 | 1 | 1 | 9 |
| GO:0030837 | negative regulation of actin filament polymerization | 2.02e-02 | 1.00e+00 | 5.615 | 1 | 1 | 9 |
| GO:0007167 | enzyme linked receptor protein signaling pathway | 2.02e-02 | 1.00e+00 | 5.615 | 1 | 1 | 9 |
| GO:0006281 | DNA repair | 2.17e-02 | 1.00e+00 | 2.326 | 3 | 22 | 264 |
| GO:0090399 | replicative senescence | 2.24e-02 | 1.00e+00 | 5.463 | 1 | 1 | 10 |
| GO:0046902 | regulation of mitochondrial membrane permeability | 2.24e-02 | 1.00e+00 | 5.463 | 1 | 1 | 10 |
| GO:0051497 | negative regulation of stress fiber assembly | 2.24e-02 | 1.00e+00 | 5.463 | 1 | 1 | 10 |
| GO:0006450 | regulation of translational fidelity | 2.24e-02 | 1.00e+00 | 5.463 | 1 | 2 | 10 |
| GO:0071318 | cellular response to ATP | 2.24e-02 | 1.00e+00 | 5.463 | 1 | 1 | 10 |
| GO:0030877 | beta-catenin destruction complex | 2.24e-02 | 1.00e+00 | 5.463 | 1 | 2 | 10 |
| GO:0043065 | positive regulation of apoptotic process | 2.39e-02 | 1.00e+00 | 2.272 | 3 | 8 | 274 |
| GO:0045945 | positive regulation of transcription from RNA polymerase III promoter | 2.47e-02 | 1.00e+00 | 5.326 | 1 | 1 | 11 |
| GO:0006693 | prostaglandin metabolic process | 2.47e-02 | 1.00e+00 | 5.326 | 1 | 1 | 11 |
| GO:0006098 | pentose-phosphate shunt | 2.47e-02 | 1.00e+00 | 5.326 | 1 | 3 | 11 |
| GO:0008340 | determination of adult lifespan | 2.47e-02 | 1.00e+00 | 5.326 | 1 | 1 | 11 |
| GO:0010569 | regulation of double-strand break repair via homologous recombination | 2.47e-02 | 1.00e+00 | 5.326 | 1 | 1 | 11 |
| GO:0071850 | mitotic cell cycle arrest | 2.47e-02 | 1.00e+00 | 5.326 | 1 | 1 | 11 |
| GO:0042633 | hair cycle | 2.69e-02 | 1.00e+00 | 5.200 | 1 | 1 | 12 |
| GO:0019372 | lipoxygenase pathway | 2.69e-02 | 1.00e+00 | 5.200 | 1 | 1 | 12 |
| GO:0070266 | necroptotic process | 2.69e-02 | 1.00e+00 | 5.200 | 1 | 1 | 12 |
| GO:0032461 | positive regulation of protein oligomerization | 2.69e-02 | 1.00e+00 | 5.200 | 1 | 1 | 12 |
| GO:0009303 | rRNA transcription | 2.69e-02 | 1.00e+00 | 5.200 | 1 | 1 | 12 |
| GO:0034236 | protein kinase A catalytic subunit binding | 2.69e-02 | 1.00e+00 | 5.200 | 1 | 1 | 12 |
| GO:0050321 | tau-protein kinase activity | 2.69e-02 | 1.00e+00 | 5.200 | 1 | 1 | 12 |
| GO:0005819 | spindle | 2.75e-02 | 1.00e+00 | 2.952 | 2 | 7 | 114 |
| GO:0048015 | phosphatidylinositol-mediated signaling | 2.79e-02 | 1.00e+00 | 2.939 | 2 | 3 | 115 |
| GO:0072562 | blood microparticle | 2.84e-02 | 1.00e+00 | 2.927 | 2 | 4 | 116 |
| GO:0046827 | positive regulation of protein export from nucleus | 2.91e-02 | 1.00e+00 | 5.085 | 1 | 2 | 13 |
| GO:0042273 | ribosomal large subunit biogenesis | 2.91e-02 | 1.00e+00 | 5.085 | 1 | 4 | 13 |
| GO:0006646 | phosphatidylethanolamine biosynthetic process | 2.91e-02 | 1.00e+00 | 5.085 | 1 | 2 | 13 |
| GO:0005662 | DNA replication factor A complex | 2.91e-02 | 1.00e+00 | 5.085 | 1 | 3 | 13 |
| GO:0051926 | negative regulation of calcium ion transport | 2.91e-02 | 1.00e+00 | 5.085 | 1 | 1 | 13 |
| GO:0031333 | negative regulation of protein complex assembly | 3.13e-02 | 1.00e+00 | 4.978 | 1 | 1 | 14 |
| GO:0001516 | prostaglandin biosynthetic process | 3.13e-02 | 1.00e+00 | 4.978 | 1 | 1 | 14 |
| GO:0006607 | NLS-bearing protein import into nucleus | 3.13e-02 | 1.00e+00 | 4.978 | 1 | 2 | 14 |
| GO:0048168 | regulation of neuronal synaptic plasticity | 3.13e-02 | 1.00e+00 | 4.978 | 1 | 1 | 14 |
| GO:0030330 | DNA damage response, signal transduction by p53 class mediator | 3.13e-02 | 1.00e+00 | 4.978 | 1 | 1 | 14 |
| GO:0070542 | response to fatty acid | 3.13e-02 | 1.00e+00 | 4.978 | 1 | 1 | 14 |
| GO:0035267 | NuA4 histone acetyltransferase complex | 3.13e-02 | 1.00e+00 | 4.978 | 1 | 4 | 14 |
| GO:0006978 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator | 3.13e-02 | 1.00e+00 | 4.978 | 1 | 2 | 14 |
| GO:2000378 | negative regulation of reactive oxygen species metabolic process | 3.13e-02 | 1.00e+00 | 4.978 | 1 | 1 | 14 |
| GO:0007020 | microtubule nucleation | 3.13e-02 | 1.00e+00 | 4.978 | 1 | 1 | 14 |
| GO:0031334 | positive regulation of protein complex assembly | 3.13e-02 | 1.00e+00 | 4.978 | 1 | 2 | 14 |
| GO:0009651 | response to salt stress | 3.13e-02 | 1.00e+00 | 4.978 | 1 | 2 | 14 |
| GO:0019371 | cyclooxygenase pathway | 3.13e-02 | 1.00e+00 | 4.978 | 1 | 1 | 14 |
| GO:0048568 | embryonic organ development | 3.13e-02 | 1.00e+00 | 4.978 | 1 | 1 | 14 |
| GO:0007219 | Notch signaling pathway | 3.25e-02 | 1.00e+00 | 2.819 | 2 | 4 | 125 |
| GO:0006349 | regulation of gene expression by genetic imprinting | 3.35e-02 | 1.00e+00 | 4.878 | 1 | 1 | 15 |
| GO:0033280 | response to vitamin D | 3.35e-02 | 1.00e+00 | 4.878 | 1 | 1 | 15 |
| GO:0046961 | proton-transporting ATPase activity, rotational mechanism | 3.35e-02 | 1.00e+00 | 4.878 | 1 | 3 | 15 |
| GO:0045987 | positive regulation of smooth muscle contraction | 3.35e-02 | 1.00e+00 | 4.878 | 1 | 1 | 15 |
| GO:0008654 | phospholipid biosynthetic process | 3.35e-02 | 1.00e+00 | 4.878 | 1 | 1 | 15 |
| GO:0048025 | negative regulation of mRNA splicing, via spliceosome | 3.35e-02 | 1.00e+00 | 4.878 | 1 | 1 | 15 |
| GO:0050998 | nitric-oxide synthase binding | 3.57e-02 | 1.00e+00 | 4.785 | 1 | 1 | 16 |
| GO:0051968 | positive regulation of synaptic transmission, glutamatergic | 3.57e-02 | 1.00e+00 | 4.785 | 1 | 1 | 16 |
| GO:0007520 | myoblast fusion | 3.57e-02 | 1.00e+00 | 4.785 | 1 | 1 | 16 |
| GO:0051603 | proteolysis involved in cellular protein catabolic process | 3.57e-02 | 1.00e+00 | 4.785 | 1 | 2 | 16 |
| GO:0046034 | ATP metabolic process | 3.57e-02 | 1.00e+00 | 4.785 | 1 | 1 | 16 |
| GO:0000790 | nuclear chromatin | 3.65e-02 | 1.00e+00 | 2.730 | 2 | 7 | 133 |
| GO:0018108 | peptidyl-tyrosine phosphorylation | 3.65e-02 | 1.00e+00 | 2.730 | 2 | 3 | 133 |
| GO:0007411 | axon guidance | 3.75e-02 | 1.00e+00 | 2.017 | 3 | 9 | 327 |
| GO:0005525 | GTP binding | 3.78e-02 | 1.00e+00 | 2.012 | 3 | 11 | 328 |
| GO:0042149 | cellular response to glucose starvation | 3.79e-02 | 1.00e+00 | 4.698 | 1 | 1 | 17 |
| GO:0035255 | ionotropic glutamate receptor binding | 3.79e-02 | 1.00e+00 | 4.698 | 1 | 1 | 17 |
| GO:0003746 | translation elongation factor activity | 3.79e-02 | 1.00e+00 | 4.698 | 1 | 3 | 17 |
| GO:0075733 | intracellular transport of virus | 3.79e-02 | 1.00e+00 | 4.698 | 1 | 2 | 17 |
| GO:0006309 | apoptotic DNA fragmentation | 3.79e-02 | 1.00e+00 | 4.698 | 1 | 1 | 17 |
| GO:0070372 | regulation of ERK1 and ERK2 cascade | 3.79e-02 | 1.00e+00 | 4.698 | 1 | 1 | 17 |
| GO:0008283 | cell proliferation | 3.87e-02 | 1.00e+00 | 1.999 | 3 | 12 | 331 |
| GO:0070064 | proline-rich region binding | 4.00e-02 | 1.00e+00 | 4.615 | 1 | 2 | 18 |
| GO:0031122 | cytoplasmic microtubule organization | 4.00e-02 | 1.00e+00 | 4.615 | 1 | 2 | 18 |
| GO:0035861 | site of double-strand break | 4.00e-02 | 1.00e+00 | 4.615 | 1 | 1 | 18 |
| GO:0010800 | positive regulation of peptidyl-threonine phosphorylation | 4.00e-02 | 1.00e+00 | 4.615 | 1 | 1 | 18 |
| GO:0005657 | replication fork | 4.00e-02 | 1.00e+00 | 4.615 | 1 | 3 | 18 |
| GO:0042346 | positive regulation of NF-kappaB import into nucleus | 4.00e-02 | 1.00e+00 | 4.615 | 1 | 2 | 18 |
| GO:0005246 | calcium channel regulator activity | 4.00e-02 | 1.00e+00 | 4.615 | 1 | 1 | 18 |
| GO:0051721 | protein phosphatase 2A binding | 4.00e-02 | 1.00e+00 | 4.615 | 1 | 1 | 18 |
| GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process | 4.22e-02 | 1.00e+00 | 4.537 | 1 | 1 | 19 |
| GO:0035035 | histone acetyltransferase binding | 4.22e-02 | 1.00e+00 | 4.537 | 1 | 1 | 19 |
| GO:0071158 | positive regulation of cell cycle arrest | 4.22e-02 | 1.00e+00 | 4.537 | 1 | 1 | 19 |
| GO:0046697 | decidualization | 4.22e-02 | 1.00e+00 | 4.537 | 1 | 1 | 19 |
| GO:0007088 | regulation of mitosis | 4.22e-02 | 1.00e+00 | 4.537 | 1 | 1 | 19 |
| GO:0010165 | response to X-ray | 4.22e-02 | 1.00e+00 | 4.537 | 1 | 2 | 19 |
| GO:0035145 | exon-exon junction complex | 4.22e-02 | 1.00e+00 | 4.537 | 1 | 2 | 19 |
| GO:0048863 | stem cell differentiation | 4.22e-02 | 1.00e+00 | 4.537 | 1 | 1 | 19 |
| GO:0004601 | peroxidase activity | 4.22e-02 | 1.00e+00 | 4.537 | 1 | 1 | 19 |
| GO:0061024 | membrane organization | 4.32e-02 | 1.00e+00 | 2.595 | 2 | 5 | 146 |
| GO:0015078 | hydrogen ion transmembrane transporter activity | 4.44e-02 | 1.00e+00 | 4.463 | 1 | 3 | 20 |
| GO:0051090 | regulation of sequence-specific DNA binding transcription factor activity | 4.44e-02 | 1.00e+00 | 4.463 | 1 | 1 | 20 |
| GO:0002931 | response to ischemia | 4.44e-02 | 1.00e+00 | 4.463 | 1 | 1 | 20 |
| GO:0008045 | motor neuron axon guidance | 4.44e-02 | 1.00e+00 | 4.463 | 1 | 1 | 20 |
| GO:0005680 | anaphase-promoting complex | 4.44e-02 | 1.00e+00 | 4.463 | 1 | 4 | 20 |
| GO:0072332 | intrinsic apoptotic signaling pathway by p53 class mediator | 4.44e-02 | 1.00e+00 | 4.463 | 1 | 1 | 20 |
| GO:0006298 | mismatch repair | 4.44e-02 | 1.00e+00 | 4.463 | 1 | 6 | 20 |
| GO:0007369 | gastrulation | 4.66e-02 | 1.00e+00 | 4.393 | 1 | 1 | 21 |
| GO:0001954 | positive regulation of cell-matrix adhesion | 4.66e-02 | 1.00e+00 | 4.393 | 1 | 1 | 21 |
| GO:0008156 | negative regulation of DNA replication | 4.66e-02 | 1.00e+00 | 4.393 | 1 | 1 | 21 |
| GO:0030010 | establishment of cell polarity | 4.66e-02 | 1.00e+00 | 4.393 | 1 | 2 | 21 |
| GO:0005669 | transcription factor TFIID complex | 4.87e-02 | 1.00e+00 | 4.326 | 1 | 1 | 22 |
| GO:0014065 | phosphatidylinositol 3-kinase signaling | 4.87e-02 | 1.00e+00 | 4.326 | 1 | 1 | 22 |
| GO:0090200 | positive regulation of release of cytochrome c from mitochondria | 4.87e-02 | 1.00e+00 | 4.326 | 1 | 1 | 22 |
| GO:0017080 | sodium channel regulator activity | 4.87e-02 | 1.00e+00 | 4.326 | 1 | 1 | 22 |
| GO:0006297 | nucleotide-excision repair, DNA gap filling | 4.87e-02 | 1.00e+00 | 4.326 | 1 | 5 | 22 |
| GO:0006656 | phosphatidylcholine biosynthetic process | 4.87e-02 | 1.00e+00 | 4.326 | 1 | 3 | 22 |
| GO:0032201 | telomere maintenance via semi-conservative replication | 4.87e-02 | 1.00e+00 | 4.326 | 1 | 7 | 22 |
| GO:0030863 | cortical cytoskeleton | 4.87e-02 | 1.00e+00 | 4.326 | 1 | 1 | 22 |
| GO:0036464 | cytoplasmic ribonucleoprotein granule | 4.87e-02 | 1.00e+00 | 4.326 | 1 | 4 | 22 |
| GO:0006974 | cellular response to DNA damage stimulus | 4.97e-02 | 1.00e+00 | 2.481 | 2 | 8 | 158 |
| GO:0045087 | innate immune response | 4.97e-02 | 1.00e+00 | 1.518 | 4 | 20 | 616 |
| GO:0008543 | fibroblast growth factor receptor signaling pathway | 5.03e-02 | 1.00e+00 | 2.472 | 2 | 4 | 159 |
| GO:0031593 | polyubiquitin binding | 5.09e-02 | 1.00e+00 | 4.261 | 1 | 1 | 23 |
| GO:0031463 | Cul3-RING ubiquitin ligase complex | 5.09e-02 | 1.00e+00 | 4.261 | 1 | 2 | 23 |
| GO:0043236 | laminin binding | 5.09e-02 | 1.00e+00 | 4.261 | 1 | 1 | 23 |
| GO:0045907 | positive regulation of vasoconstriction | 5.09e-02 | 1.00e+00 | 4.261 | 1 | 1 | 23 |
| GO:0010575 | positive regulation vascular endothelial growth factor production | 5.09e-02 | 1.00e+00 | 4.261 | 1 | 1 | 23 |
| GO:0006513 | protein monoubiquitination | 5.09e-02 | 1.00e+00 | 4.261 | 1 | 1 | 23 |
| GO:0048709 | oligodendrocyte differentiation | 5.09e-02 | 1.00e+00 | 4.261 | 1 | 1 | 23 |
| GO:0043044 | ATP-dependent chromatin remodeling | 5.09e-02 | 1.00e+00 | 4.261 | 1 | 4 | 23 |
| GO:0043005 | neuron projection | 5.14e-02 | 1.00e+00 | 2.454 | 2 | 4 | 161 |
| GO:0008135 | translation factor activity, nucleic acid binding | 5.30e-02 | 1.00e+00 | 4.200 | 1 | 4 | 24 |
| GO:0010634 | positive regulation of epithelial cell migration | 5.30e-02 | 1.00e+00 | 4.200 | 1 | 1 | 24 |
| GO:0001836 | release of cytochrome c from mitochondria | 5.30e-02 | 1.00e+00 | 4.200 | 1 | 2 | 24 |
| GO:0045765 | regulation of angiogenesis | 5.30e-02 | 1.00e+00 | 4.200 | 1 | 1 | 24 |
| GO:0048147 | negative regulation of fibroblast proliferation | 5.30e-02 | 1.00e+00 | 4.200 | 1 | 1 | 24 |
| GO:0000794 | condensed nuclear chromosome | 5.30e-02 | 1.00e+00 | 4.200 | 1 | 2 | 24 |
| GO:0005977 | glycogen metabolic process | 5.30e-02 | 1.00e+00 | 4.200 | 1 | 1 | 24 |
| GO:2000379 | positive regulation of reactive oxygen species metabolic process | 5.30e-02 | 1.00e+00 | 4.200 | 1 | 1 | 24 |
| GO:0006611 | protein export from nucleus | 5.52e-02 | 1.00e+00 | 4.141 | 1 | 4 | 25 |
| GO:0032781 | positive regulation of ATPase activity | 5.52e-02 | 1.00e+00 | 4.141 | 1 | 1 | 25 |
| GO:0001816 | cytokine production | 5.52e-02 | 1.00e+00 | 4.141 | 1 | 1 | 25 |
| GO:0008536 | Ran GTPase binding | 5.52e-02 | 1.00e+00 | 4.141 | 1 | 2 | 25 |
| GO:0030016 | myofibril | 5.52e-02 | 1.00e+00 | 4.141 | 1 | 1 | 25 |
| GO:0071479 | cellular response to ionizing radiation | 5.52e-02 | 1.00e+00 | 4.141 | 1 | 1 | 25 |
| GO:0007569 | cell aging | 5.52e-02 | 1.00e+00 | 4.141 | 1 | 2 | 25 |
| GO:0019838 | growth factor binding | 5.52e-02 | 1.00e+00 | 4.141 | 1 | 1 | 25 |
| GO:0006397 | mRNA processing | 5.61e-02 | 1.00e+00 | 2.384 | 2 | 3 | 169 |
| GO:0070979 | protein K11-linked ubiquitination | 5.73e-02 | 1.00e+00 | 4.085 | 1 | 3 | 26 |
| GO:0061418 | regulation of transcription from RNA polymerase II promoter in response to hypoxia | 5.73e-02 | 1.00e+00 | 4.085 | 1 | 2 | 26 |
| GO:0015459 | potassium channel regulator activity | 5.73e-02 | 1.00e+00 | 4.085 | 1 | 1 | 26 |
| GO:1900740 | positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway | 5.73e-02 | 1.00e+00 | 4.085 | 1 | 3 | 26 |
| GO:0000722 | telomere maintenance via recombination | 5.73e-02 | 1.00e+00 | 4.085 | 1 | 7 | 26 |
| GO:0007616 | long-term memory | 5.95e-02 | 1.00e+00 | 4.030 | 1 | 1 | 27 |
| GO:0019843 | rRNA binding | 5.95e-02 | 1.00e+00 | 4.030 | 1 | 3 | 27 |
| GO:0007422 | peripheral nervous system development | 5.95e-02 | 1.00e+00 | 4.030 | 1 | 1 | 27 |
| GO:0016607 | nuclear speck | 5.96e-02 | 1.00e+00 | 2.334 | 2 | 4 | 175 |
| GO:0015991 | ATP hydrolysis coupled proton transport | 6.16e-02 | 1.00e+00 | 3.978 | 1 | 4 | 28 |
| GO:0043022 | ribosome binding | 6.16e-02 | 1.00e+00 | 3.978 | 1 | 3 | 28 |
| GO:0031492 | nucleosomal DNA binding | 6.16e-02 | 1.00e+00 | 3.978 | 1 | 4 | 28 |
| GO:0019894 | kinesin binding | 6.16e-02 | 1.00e+00 | 3.978 | 1 | 1 | 28 |
| GO:0034612 | response to tumor necrosis factor | 6.16e-02 | 1.00e+00 | 3.978 | 1 | 2 | 28 |
| GO:0000118 | histone deacetylase complex | 6.16e-02 | 1.00e+00 | 3.978 | 1 | 1 | 28 |
| GO:0000381 | regulation of alternative mRNA splicing, via spliceosome | 6.38e-02 | 1.00e+00 | 3.927 | 1 | 2 | 29 |
| GO:0006099 | tricarboxylic acid cycle | 6.38e-02 | 1.00e+00 | 3.927 | 1 | 3 | 29 |
| GO:0019005 | SCF ubiquitin ligase complex | 6.38e-02 | 1.00e+00 | 3.927 | 1 | 1 | 29 |
| GO:0043198 | dendritic shaft | 6.38e-02 | 1.00e+00 | 3.927 | 1 | 1 | 29 |
| GO:0010332 | response to gamma radiation | 6.38e-02 | 1.00e+00 | 3.927 | 1 | 2 | 29 |
| GO:0004712 | protein serine/threonine/tyrosine kinase activity | 6.38e-02 | 1.00e+00 | 3.927 | 1 | 1 | 29 |
| GO:0030669 | clathrin-coated endocytic vesicle membrane | 6.38e-02 | 1.00e+00 | 3.927 | 1 | 1 | 29 |
| GO:0006606 | protein import into nucleus | 6.59e-02 | 1.00e+00 | 3.878 | 1 | 1 | 30 |
| GO:0023014 | signal transduction by phosphorylation | 6.59e-02 | 1.00e+00 | 3.878 | 1 | 1 | 30 |
| GO:0051262 | protein tetramerization | 6.59e-02 | 1.00e+00 | 3.878 | 1 | 3 | 30 |
| GO:0021549 | cerebellum development | 6.59e-02 | 1.00e+00 | 3.878 | 1 | 1 | 30 |
| GO:0004714 | transmembrane receptor protein tyrosine kinase activity | 6.59e-02 | 1.00e+00 | 3.878 | 1 | 2 | 30 |
| GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator | 6.59e-02 | 1.00e+00 | 3.878 | 1 | 2 | 30 |
| GO:0050873 | brown fat cell differentiation | 6.80e-02 | 1.00e+00 | 3.831 | 1 | 2 | 31 |
| GO:0006271 | DNA strand elongation involved in DNA replication | 6.80e-02 | 1.00e+00 | 3.831 | 1 | 9 | 31 |
| GO:0017048 | Rho GTPase binding | 6.80e-02 | 1.00e+00 | 3.831 | 1 | 1 | 31 |
| GO:0031623 | receptor internalization | 6.80e-02 | 1.00e+00 | 3.831 | 1 | 1 | 31 |
| GO:0046677 | response to antibiotic | 6.80e-02 | 1.00e+00 | 3.831 | 1 | 2 | 31 |
| GO:0016604 | nuclear body | 6.80e-02 | 1.00e+00 | 3.831 | 1 | 2 | 31 |
| GO:0007094 | mitotic spindle assembly checkpoint | 6.80e-02 | 1.00e+00 | 3.831 | 1 | 5 | 31 |
| GO:0007173 | epidermal growth factor receptor signaling pathway | 6.95e-02 | 1.00e+00 | 2.208 | 2 | 4 | 191 |
| GO:0050661 | NADP binding | 7.01e-02 | 1.00e+00 | 3.785 | 1 | 1 | 32 |
| GO:0002250 | adaptive immune response | 7.01e-02 | 1.00e+00 | 3.785 | 1 | 1 | 32 |
| GO:1903507 | negative regulation of nucleic acid-templated transcription | 7.01e-02 | 1.00e+00 | 3.785 | 1 | 2 | 32 |
| GO:0007528 | neuromuscular junction development | 7.01e-02 | 1.00e+00 | 3.785 | 1 | 1 | 32 |
| GO:0015992 | proton transport | 7.01e-02 | 1.00e+00 | 3.785 | 1 | 3 | 32 |
| GO:0032091 | negative regulation of protein binding | 7.22e-02 | 1.00e+00 | 3.741 | 1 | 1 | 33 |
| GO:2001244 | positive regulation of intrinsic apoptotic signaling pathway | 7.22e-02 | 1.00e+00 | 3.741 | 1 | 1 | 33 |
| GO:0030282 | bone mineralization | 7.22e-02 | 1.00e+00 | 3.741 | 1 | 1 | 33 |
| GO:0030971 | receptor tyrosine kinase binding | 7.22e-02 | 1.00e+00 | 3.741 | 1 | 2 | 33 |
| GO:0001837 | epithelial to mesenchymal transition | 7.22e-02 | 1.00e+00 | 3.741 | 1 | 1 | 33 |
| GO:0033077 | T cell differentiation in thymus | 7.22e-02 | 1.00e+00 | 3.741 | 1 | 2 | 33 |
| GO:0030017 | sarcomere | 7.43e-02 | 1.00e+00 | 3.698 | 1 | 1 | 34 |
| GO:0004175 | endopeptidase activity | 7.43e-02 | 1.00e+00 | 3.698 | 1 | 2 | 34 |
| GO:0043407 | negative regulation of MAP kinase activity | 7.43e-02 | 1.00e+00 | 3.698 | 1 | 1 | 34 |
| GO:0051701 | interaction with host | 7.43e-02 | 1.00e+00 | 3.698 | 1 | 4 | 34 |
| GO:0005876 | spindle microtubule | 7.43e-02 | 1.00e+00 | 3.698 | 1 | 3 | 34 |
| GO:0097192 | extrinsic apoptotic signaling pathway in absence of ligand | 7.64e-02 | 1.00e+00 | 3.656 | 1 | 2 | 35 |
| GO:0045429 | positive regulation of nitric oxide biosynthetic process | 7.64e-02 | 1.00e+00 | 3.656 | 1 | 3 | 35 |
| GO:0032588 | trans-Golgi network membrane | 7.85e-02 | 1.00e+00 | 3.615 | 1 | 1 | 36 |
| GO:0034332 | adherens junction organization | 7.85e-02 | 1.00e+00 | 3.615 | 1 | 1 | 36 |
| GO:0051402 | neuron apoptotic process | 7.85e-02 | 1.00e+00 | 3.615 | 1 | 2 | 36 |
| GO:0032855 | positive regulation of Rac GTPase activity | 7.85e-02 | 1.00e+00 | 3.615 | 1 | 1 | 36 |
| GO:0007566 | embryo implantation | 7.85e-02 | 1.00e+00 | 3.615 | 1 | 1 | 36 |
| GO:0030838 | positive regulation of actin filament polymerization | 7.85e-02 | 1.00e+00 | 3.615 | 1 | 2 | 36 |
| GO:0042552 | myelination | 7.85e-02 | 1.00e+00 | 3.615 | 1 | 1 | 36 |
| GO:0001895 | retina homeostasis | 7.85e-02 | 1.00e+00 | 3.615 | 1 | 1 | 36 |
| GO:0016301 | kinase activity | 8.06e-02 | 1.00e+00 | 3.576 | 1 | 3 | 37 |
| GO:0051084 | 'de novo' posttranslational protein folding | 8.06e-02 | 1.00e+00 | 3.576 | 1 | 4 | 37 |
| GO:0051539 | 4 iron, 4 sulfur cluster binding | 8.06e-02 | 1.00e+00 | 3.576 | 1 | 3 | 37 |
| GO:0001701 | in utero embryonic development | 8.18e-02 | 1.00e+00 | 2.071 | 2 | 6 | 210 |
| GO:0001756 | somitogenesis | 8.27e-02 | 1.00e+00 | 3.537 | 1 | 1 | 38 |
| GO:0070527 | platelet aggregation | 8.27e-02 | 1.00e+00 | 3.537 | 1 | 2 | 38 |
| GO:0090382 | phagosome maturation | 8.27e-02 | 1.00e+00 | 3.537 | 1 | 5 | 38 |
| GO:0051496 | positive regulation of stress fiber assembly | 8.48e-02 | 1.00e+00 | 3.500 | 1 | 2 | 39 |
| GO:0032092 | positive regulation of protein binding | 8.48e-02 | 1.00e+00 | 3.500 | 1 | 3 | 39 |
| GO:0021766 | hippocampus development | 8.48e-02 | 1.00e+00 | 3.500 | 1 | 4 | 39 |
| GO:0001228 | RNA polymerase II transcription regulatory region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription | 8.69e-02 | 1.00e+00 | 3.463 | 1 | 2 | 40 |
| GO:0000781 | chromosome, telomeric region | 8.69e-02 | 1.00e+00 | 3.463 | 1 | 2 | 40 |
| GO:0007596 | blood coagulation | 8.72e-02 | 1.00e+00 | 1.512 | 3 | 14 | 464 |
| GO:0006468 | protein phosphorylation | 8.85e-02 | 1.00e+00 | 1.503 | 3 | 10 | 467 |
| GO:0045786 | negative regulation of cell cycle | 8.90e-02 | 1.00e+00 | 3.427 | 1 | 1 | 41 |
| GO:0045785 | positive regulation of cell adhesion | 8.90e-02 | 1.00e+00 | 3.427 | 1 | 5 | 41 |
| GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding | 8.90e-02 | 1.00e+00 | 3.427 | 1 | 2 | 41 |
| GO:0071363 | cellular response to growth factor stimulus | 9.10e-02 | 1.00e+00 | 3.393 | 1 | 2 | 42 |
| GO:0006418 | tRNA aminoacylation for protein translation | 9.10e-02 | 1.00e+00 | 3.393 | 1 | 5 | 42 |
| GO:0005902 | microvillus | 9.10e-02 | 1.00e+00 | 3.393 | 1 | 2 | 42 |
| GO:0043647 | inositol phosphate metabolic process | 9.10e-02 | 1.00e+00 | 3.393 | 1 | 1 | 42 |
| GO:0004715 | non-membrane spanning protein tyrosine kinase activity | 9.10e-02 | 1.00e+00 | 3.393 | 1 | 1 | 42 |
| GO:0042110 | T cell activation | 9.31e-02 | 1.00e+00 | 3.359 | 1 | 3 | 43 |
| GO:0032436 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process | 9.52e-02 | 1.00e+00 | 3.326 | 1 | 3 | 44 |
| GO:0034613 | cellular protein localization | 9.52e-02 | 1.00e+00 | 3.326 | 1 | 1 | 44 |
| GO:0006892 | post-Golgi vesicle-mediated transport | 9.52e-02 | 1.00e+00 | 3.326 | 1 | 2 | 44 |
| GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding | 9.52e-02 | 1.00e+00 | 3.326 | 1 | 2 | 44 |
| GO:0050434 | positive regulation of viral transcription | 9.52e-02 | 1.00e+00 | 3.326 | 1 | 5 | 44 |
| GO:0007067 | mitotic nuclear division | 9.62e-02 | 1.00e+00 | 1.933 | 2 | 13 | 231 |
| GO:0008380 | RNA splicing | 9.69e-02 | 1.00e+00 | 1.927 | 2 | 13 | 232 |
| GO:0015030 | Cajal body | 9.72e-02 | 1.00e+00 | 3.293 | 1 | 2 | 45 |
| GO:0005759 | mitochondrial matrix | 9.76e-02 | 1.00e+00 | 1.921 | 2 | 12 | 233 |
| GO:0030136 | clathrin-coated vesicle | 9.93e-02 | 1.00e+00 | 3.261 | 1 | 1 | 46 |
| GO:0043525 | positive regulation of neuron apoptotic process | 9.93e-02 | 1.00e+00 | 3.261 | 1 | 2 | 46 |
| GO:0006283 | transcription-coupled nucleotide-excision repair | 9.93e-02 | 1.00e+00 | 3.261 | 1 | 8 | 46 |
| GO:0021762 | substantia nigra development | 9.93e-02 | 1.00e+00 | 3.261 | 1 | 1 | 46 |
| GO:0007612 | learning | 9.93e-02 | 1.00e+00 | 3.261 | 1 | 1 | 46 |
| GO:0043406 | positive regulation of MAP kinase activity | 1.01e-01 | 1.00e+00 | 3.230 | 1 | 2 | 47 |
| GO:0006921 | cellular component disassembly involved in execution phase of apoptosis | 1.01e-01 | 1.00e+00 | 3.230 | 1 | 5 | 47 |
| GO:0005507 | copper ion binding | 1.03e-01 | 1.00e+00 | 3.200 | 1 | 2 | 48 |
| GO:0006950 | response to stress | 1.03e-01 | 1.00e+00 | 3.200 | 1 | 3 | 48 |
| GO:0022625 | cytosolic large ribosomal subunit | 1.05e-01 | 1.00e+00 | 3.170 | 1 | 5 | 49 |
| GO:0048661 | positive regulation of smooth muscle cell proliferation | 1.05e-01 | 1.00e+00 | 3.170 | 1 | 2 | 49 |
| GO:0019369 | arachidonic acid metabolic process | 1.05e-01 | 1.00e+00 | 3.170 | 1 | 2 | 49 |
| GO:0003743 | translation initiation factor activity | 1.05e-01 | 1.00e+00 | 3.170 | 1 | 4 | 49 |
| GO:0019233 | sensory perception of pain | 1.05e-01 | 1.00e+00 | 3.170 | 1 | 1 | 49 |
| GO:0035690 | cellular response to drug | 1.07e-01 | 1.00e+00 | 3.141 | 1 | 2 | 50 |
| GO:0006091 | generation of precursor metabolites and energy | 1.09e-01 | 1.00e+00 | 3.113 | 1 | 3 | 51 |
| GO:0045444 | fat cell differentiation | 1.09e-01 | 1.00e+00 | 3.113 | 1 | 1 | 51 |
| GO:0045732 | positive regulation of protein catabolic process | 1.09e-01 | 1.00e+00 | 3.113 | 1 | 4 | 51 |
| GO:0030334 | regulation of cell migration | 1.11e-01 | 1.00e+00 | 3.085 | 1 | 2 | 52 |
| GO:0003725 | double-stranded RNA binding | 1.16e-01 | 1.00e+00 | 3.030 | 1 | 6 | 54 |
| GO:0007623 | circadian rhythm | 1.16e-01 | 1.00e+00 | 3.030 | 1 | 1 | 54 |
| GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding | 1.16e-01 | 1.00e+00 | 3.030 | 1 | 5 | 54 |
| GO:0050679 | positive regulation of epithelial cell proliferation | 1.16e-01 | 1.00e+00 | 3.030 | 1 | 1 | 54 |
| GO:0097193 | intrinsic apoptotic signaling pathway | 1.18e-01 | 1.00e+00 | 3.004 | 1 | 4 | 55 |
| GO:0000226 | microtubule cytoskeleton organization | 1.18e-01 | 1.00e+00 | 3.004 | 1 | 3 | 55 |
| GO:0006814 | sodium ion transport | 1.18e-01 | 1.00e+00 | 3.004 | 1 | 1 | 55 |
| GO:0007613 | memory | 1.20e-01 | 1.00e+00 | 2.978 | 1 | 2 | 56 |
| GO:0008104 | protein localization | 1.20e-01 | 1.00e+00 | 2.978 | 1 | 3 | 56 |
| GO:0006968 | cellular defense response | 1.20e-01 | 1.00e+00 | 2.978 | 1 | 1 | 56 |
| GO:0008565 | protein transporter activity | 1.22e-01 | 1.00e+00 | 2.952 | 1 | 2 | 57 |
| GO:0006879 | cellular iron ion homeostasis | 1.22e-01 | 1.00e+00 | 2.952 | 1 | 5 | 57 |
| GO:0000724 | double-strand break repair via homologous recombination | 1.22e-01 | 1.00e+00 | 2.952 | 1 | 6 | 57 |
| GO:0012505 | endomembrane system | 1.22e-01 | 1.00e+00 | 2.952 | 1 | 2 | 57 |
| GO:0007202 | activation of phospholipase C activity | 1.24e-01 | 1.00e+00 | 2.927 | 1 | 1 | 58 |
| GO:0002244 | hematopoietic progenitor cell differentiation | 1.24e-01 | 1.00e+00 | 2.927 | 1 | 1 | 58 |
| GO:0051087 | chaperone binding | 1.26e-01 | 1.00e+00 | 2.902 | 1 | 6 | 59 |
| GO:0045216 | cell-cell junction organization | 1.26e-01 | 1.00e+00 | 2.902 | 1 | 2 | 59 |
| GO:0000723 | telomere maintenance | 1.26e-01 | 1.00e+00 | 2.902 | 1 | 8 | 59 |
| GO:0005643 | nuclear pore | 1.26e-01 | 1.00e+00 | 2.902 | 1 | 4 | 59 |
| GO:0005840 | ribosome | 1.26e-01 | 1.00e+00 | 2.902 | 1 | 2 | 59 |
| GO:0048011 | neurotrophin TRK receptor signaling pathway | 1.27e-01 | 1.00e+00 | 1.692 | 2 | 6 | 273 |
| GO:0008013 | beta-catenin binding | 1.28e-01 | 1.00e+00 | 2.878 | 1 | 4 | 60 |
| GO:0007169 | transmembrane receptor protein tyrosine kinase signaling pathway | 1.30e-01 | 1.00e+00 | 2.854 | 1 | 2 | 61 |
| GO:0033138 | positive regulation of peptidyl-serine phosphorylation | 1.30e-01 | 1.00e+00 | 2.854 | 1 | 3 | 61 |
| GO:0051384 | response to glucocorticoid | 1.31e-01 | 1.00e+00 | 2.831 | 1 | 2 | 62 |
| GO:0005901 | caveola | 1.33e-01 | 1.00e+00 | 2.808 | 1 | 3 | 63 |
| GO:0030512 | negative regulation of transforming growth factor beta receptor signaling pathway | 1.35e-01 | 1.00e+00 | 2.785 | 1 | 1 | 64 |
| GO:0042493 | response to drug | 1.38e-01 | 1.00e+00 | 1.615 | 2 | 11 | 288 |
| GO:0001558 | regulation of cell growth | 1.39e-01 | 1.00e+00 | 2.741 | 1 | 4 | 66 |
| GO:0042060 | wound healing | 1.43e-01 | 1.00e+00 | 2.698 | 1 | 1 | 68 |
| GO:0018105 | peptidyl-serine phosphorylation | 1.45e-01 | 1.00e+00 | 2.676 | 1 | 1 | 69 |
| GO:0050790 | regulation of catalytic activity | 1.45e-01 | 1.00e+00 | 2.676 | 1 | 3 | 69 |
| GO:0030307 | positive regulation of cell growth | 1.47e-01 | 1.00e+00 | 2.656 | 1 | 2 | 70 |
| GO:0035264 | multicellular organism growth | 1.47e-01 | 1.00e+00 | 2.656 | 1 | 1 | 70 |
| GO:0034329 | cell junction assembly | 1.49e-01 | 1.00e+00 | 2.635 | 1 | 1 | 71 |
| GO:0032355 | response to estradiol | 1.53e-01 | 1.00e+00 | 2.595 | 1 | 5 | 73 |
| GO:0000785 | chromatin | 1.53e-01 | 1.00e+00 | 2.595 | 1 | 5 | 73 |
| GO:0002020 | protease binding | 1.55e-01 | 1.00e+00 | 2.576 | 1 | 4 | 74 |
| GO:0005856 | cytoskeleton | 1.56e-01 | 1.00e+00 | 1.504 | 2 | 8 | 311 |
| GO:0004674 | protein serine/threonine kinase activity | 1.57e-01 | 1.00e+00 | 1.500 | 2 | 6 | 312 |
| GO:0001843 | neural tube closure | 1.57e-01 | 1.00e+00 | 2.556 | 1 | 2 | 75 |
| GO:0007265 | Ras protein signal transduction | 1.57e-01 | 1.00e+00 | 2.556 | 1 | 3 | 75 |
| GO:0060070 | canonical Wnt signaling pathway | 1.57e-01 | 1.00e+00 | 2.556 | 1 | 3 | 75 |
| GO:0050731 | positive regulation of peptidyl-tyrosine phosphorylation | 1.57e-01 | 1.00e+00 | 2.556 | 1 | 1 | 75 |
| GO:0046474 | glycerophospholipid biosynthetic process | 1.59e-01 | 1.00e+00 | 2.537 | 1 | 3 | 76 |
| GO:0035556 | intracellular signal transduction | 1.61e-01 | 1.00e+00 | 1.477 | 2 | 6 | 317 |
| GO:0038096 | Fc-gamma receptor signaling pathway involved in phagocytosis | 1.61e-01 | 1.00e+00 | 2.518 | 1 | 5 | 77 |
| GO:0008584 | male gonad development | 1.61e-01 | 1.00e+00 | 2.518 | 1 | 2 | 77 |
| GO:0071013 | catalytic step 2 spliceosome | 1.65e-01 | 1.00e+00 | 2.481 | 1 | 7 | 79 |
| GO:0030154 | cell differentiation | 1.68e-01 | 1.00e+00 | 1.441 | 2 | 5 | 325 |
| GO:0001726 | ruffle | 1.70e-01 | 1.00e+00 | 2.427 | 1 | 4 | 82 |
| GO:0002576 | platelet degranulation | 1.70e-01 | 1.00e+00 | 2.427 | 1 | 4 | 82 |
| GO:0004713 | protein tyrosine kinase activity | 1.70e-01 | 1.00e+00 | 2.427 | 1 | 2 | 82 |
| GO:0005681 | spliceosomal complex | 1.72e-01 | 1.00e+00 | 2.410 | 1 | 3 | 83 |
| GO:0043197 | dendritic spine | 1.72e-01 | 1.00e+00 | 2.410 | 1 | 2 | 83 |
| GO:0006898 | receptor-mediated endocytosis | 1.78e-01 | 1.00e+00 | 2.359 | 1 | 2 | 86 |
| GO:0050852 | T cell receptor signaling pathway | 1.81e-01 | 1.00e+00 | 2.326 | 1 | 2 | 88 |
| GO:0090090 | negative regulation of canonical Wnt signaling pathway | 1.81e-01 | 1.00e+00 | 2.326 | 1 | 3 | 88 |
| GO:0032321 | positive regulation of Rho GTPase activity | 1.81e-01 | 1.00e+00 | 2.326 | 1 | 1 | 88 |
| GO:0009887 | organ morphogenesis | 1.83e-01 | 1.00e+00 | 2.309 | 1 | 2 | 89 |
| GO:0006979 | response to oxidative stress | 1.85e-01 | 1.00e+00 | 2.293 | 1 | 4 | 90 |
| GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II | 1.89e-01 | 1.00e+00 | 2.261 | 1 | 4 | 92 |
| GO:0016310 | phosphorylation | 1.94e-01 | 1.00e+00 | 2.215 | 1 | 2 | 95 |
| GO:0006364 | rRNA processing | 1.96e-01 | 1.00e+00 | 2.200 | 1 | 5 | 96 |
| GO:0030426 | growth cone | 1.98e-01 | 1.00e+00 | 2.185 | 1 | 3 | 97 |
| GO:0005178 | integrin binding | 1.98e-01 | 1.00e+00 | 2.185 | 1 | 2 | 97 |
| GO:0008285 | negative regulation of cell proliferation | 2.02e-01 | 1.00e+00 | 1.265 | 2 | 11 | 367 |
| GO:0004888 | transmembrane signaling receptor activity | 2.09e-01 | 1.00e+00 | 2.098 | 1 | 1 | 103 |
| GO:0043235 | receptor complex | 2.11e-01 | 1.00e+00 | 2.085 | 1 | 2 | 104 |
| GO:0005739 | mitochondrion | 2.11e-01 | 1.00e+00 | 0.754 | 4 | 24 | 1046 |
| GO:0014069 | postsynaptic density | 2.14e-01 | 1.00e+00 | 2.057 | 1 | 1 | 106 |
| GO:0001934 | positive regulation of protein phosphorylation | 2.18e-01 | 1.00e+00 | 2.030 | 1 | 5 | 108 |
| GO:0031410 | cytoplasmic vesicle | 2.22e-01 | 1.00e+00 | 2.004 | 1 | 2 | 110 |
| GO:0042127 | regulation of cell proliferation | 2.23e-01 | 1.00e+00 | 1.991 | 1 | 4 | 111 |
| GO:0020037 | heme binding | 2.23e-01 | 1.00e+00 | 1.991 | 1 | 2 | 111 |
| GO:0006461 | protein complex assembly | 2.23e-01 | 1.00e+00 | 1.991 | 1 | 6 | 111 |
| GO:0015630 | microtubule cytoskeleton | 2.25e-01 | 1.00e+00 | 1.978 | 1 | 5 | 112 |
| GO:0030308 | negative regulation of cell growth | 2.27e-01 | 1.00e+00 | 1.965 | 1 | 6 | 113 |
| GO:0046982 | protein heterodimerization activity | 2.29e-01 | 1.00e+00 | 1.145 | 2 | 11 | 399 |
| GO:0008289 | lipid binding | 2.32e-01 | 1.00e+00 | 1.927 | 1 | 1 | 116 |
| GO:0005635 | nuclear envelope | 2.32e-01 | 1.00e+00 | 1.927 | 1 | 6 | 116 |
| GO:0044237 | cellular metabolic process | 2.36e-01 | 1.00e+00 | 1.902 | 1 | 3 | 118 |
| GO:0032496 | response to lipopolysaccharide | 2.43e-01 | 1.00e+00 | 1.854 | 1 | 4 | 122 |
| GO:0006325 | chromatin organization | 2.44e-01 | 1.00e+00 | 1.842 | 1 | 4 | 123 |
| GO:0051092 | positive regulation of NF-kappaB transcription factor activity | 2.48e-01 | 1.00e+00 | 1.819 | 1 | 4 | 125 |
| GO:0006260 | DNA replication | 2.48e-01 | 1.00e+00 | 1.819 | 1 | 12 | 125 |
| GO:0007050 | cell cycle arrest | 2.50e-01 | 1.00e+00 | 1.808 | 1 | 7 | 126 |
| GO:0006511 | ubiquitin-dependent protein catabolic process | 2.51e-01 | 1.00e+00 | 1.796 | 1 | 5 | 127 |
| GO:0005506 | iron ion binding | 2.51e-01 | 1.00e+00 | 1.796 | 1 | 3 | 127 |
| GO:0030036 | actin cytoskeleton organization | 2.55e-01 | 1.00e+00 | 1.774 | 1 | 5 | 129 |
| GO:0007179 | transforming growth factor beta receptor signaling pathway | 2.56e-01 | 1.00e+00 | 1.763 | 1 | 3 | 130 |
| GO:0016477 | cell migration | 2.58e-01 | 1.00e+00 | 1.752 | 1 | 6 | 131 |
| GO:0046983 | protein dimerization activity | 2.58e-01 | 1.00e+00 | 1.752 | 1 | 3 | 131 |
| GO:0009615 | response to virus | 2.60e-01 | 1.00e+00 | 1.741 | 1 | 6 | 132 |
| GO:0031982 | vesicle | 2.63e-01 | 1.00e+00 | 1.719 | 1 | 10 | 134 |
| GO:0006644 | phospholipid metabolic process | 2.68e-01 | 1.00e+00 | 1.687 | 1 | 5 | 137 |
| GO:0000086 | G2/M transition of mitotic cell cycle | 2.68e-01 | 1.00e+00 | 1.687 | 1 | 7 | 137 |
| GO:0045202 | synapse | 2.73e-01 | 1.00e+00 | 1.656 | 1 | 3 | 140 |
| GO:0007507 | heart development | 2.75e-01 | 1.00e+00 | 1.645 | 1 | 5 | 141 |
| GO:0005911 | cell-cell junction | 2.77e-01 | 1.00e+00 | 1.635 | 1 | 3 | 142 |
| GO:0045944 | positive regulation of transcription from RNA polymerase II promoter | 2.78e-01 | 1.00e+00 | 0.706 | 3 | 19 | 811 |
| GO:0016887 | ATPase activity | 2.80e-01 | 1.00e+00 | 1.615 | 1 | 7 | 144 |
| GO:0008286 | insulin receptor signaling pathway | 2.80e-01 | 1.00e+00 | 1.615 | 1 | 6 | 144 |
| GO:0010628 | positive regulation of gene expression | 2.88e-01 | 1.00e+00 | 1.566 | 1 | 4 | 149 |
| GO:0006457 | protein folding | 2.88e-01 | 1.00e+00 | 1.566 | 1 | 8 | 149 |
| GO:0007166 | cell surface receptor signaling pathway | 2.88e-01 | 1.00e+00 | 1.566 | 1 | 1 | 149 |
| GO:0016323 | basolateral plasma membrane | 2.88e-01 | 1.00e+00 | 1.566 | 1 | 3 | 149 |
| GO:0001077 | RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription | 2.91e-01 | 1.00e+00 | 1.547 | 1 | 2 | 151 |
| GO:0055114 | oxidation-reduction process | 2.98e-01 | 1.00e+00 | 0.875 | 2 | 11 | 481 |
| GO:0010008 | endosome membrane | 3.01e-01 | 1.00e+00 | 1.490 | 1 | 6 | 157 |
| GO:0046777 | protein autophosphorylation | 3.03e-01 | 1.00e+00 | 1.481 | 1 | 3 | 158 |
| GO:0005198 | structural molecule activity | 3.04e-01 | 1.00e+00 | 1.472 | 1 | 4 | 159 |
| GO:0042802 | identical protein binding | 3.06e-01 | 1.00e+00 | 0.845 | 2 | 18 | 491 |
| GO:0045121 | membrane raft | 3.07e-01 | 1.00e+00 | 1.454 | 1 | 8 | 161 |
| GO:0008022 | protein C-terminus binding | 3.07e-01 | 1.00e+00 | 1.454 | 1 | 4 | 161 |
| GO:0000398 | mRNA splicing, via spliceosome | 3.14e-01 | 1.00e+00 | 1.419 | 1 | 12 | 165 |
| GO:0034220 | ion transmembrane transport | 3.17e-01 | 1.00e+00 | 1.401 | 1 | 2 | 167 |
| GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding | 3.18e-01 | 1.00e+00 | 1.393 | 1 | 5 | 168 |
| GO:0044212 | transcription regulatory region DNA binding | 3.23e-01 | 1.00e+00 | 1.367 | 1 | 6 | 171 |
| GO:0030424 | axon | 3.25e-01 | 1.00e+00 | 1.359 | 1 | 3 | 172 |
| GO:0006886 | intracellular protein transport | 3.26e-01 | 1.00e+00 | 1.350 | 1 | 4 | 173 |
| GO:0055085 | transmembrane transport | 3.26e-01 | 1.00e+00 | 0.779 | 2 | 8 | 514 |
| GO:0031965 | nuclear membrane | 3.31e-01 | 1.00e+00 | 1.326 | 1 | 4 | 176 |
| GO:0048471 | perinuclear region of cytoplasm | 3.33e-01 | 1.00e+00 | 0.754 | 2 | 12 | 523 |
| GO:0003714 | transcription corepressor activity | 3.35e-01 | 1.00e+00 | 1.301 | 1 | 7 | 179 |
| GO:0019904 | protein domain specific binding | 3.38e-01 | 1.00e+00 | 1.285 | 1 | 6 | 181 |
| GO:0032403 | protein complex binding | 3.44e-01 | 1.00e+00 | 1.254 | 1 | 7 | 185 |
| GO:0001525 | angiogenesis | 3.67e-01 | 1.00e+00 | 1.141 | 1 | 4 | 200 |
| GO:0030168 | platelet activation | 3.74e-01 | 1.00e+00 | 1.106 | 1 | 9 | 205 |
| GO:0005765 | lysosomal membrane | 3.92e-01 | 1.00e+00 | 1.017 | 1 | 5 | 218 |
| GO:0016324 | apical plasma membrane | 4.01e-01 | 1.00e+00 | 0.978 | 1 | 2 | 224 |
| GO:0019221 | cytokine-mediated signaling pathway | 4.09e-01 | 1.00e+00 | 0.939 | 1 | 3 | 230 |
| GO:0005789 | endoplasmic reticulum membrane | 4.26e-01 | 1.00e+00 | 0.472 | 2 | 10 | 636 |
| GO:0008134 | transcription factor binding | 4.30e-01 | 1.00e+00 | 0.842 | 1 | 8 | 246 |
| GO:0008270 | zinc ion binding | 4.39e-01 | 1.00e+00 | 0.311 | 3 | 12 | 1067 |
| GO:0043025 | neuronal cell body | 4.41e-01 | 1.00e+00 | 0.796 | 1 | 4 | 254 |
| GO:0004842 | ubiquitin-protein transferase activity | 4.43e-01 | 1.00e+00 | 0.785 | 1 | 4 | 256 |
| GO:0005102 | receptor binding | 4.58e-01 | 1.00e+00 | 0.719 | 1 | 5 | 268 |
| GO:0005975 | carbohydrate metabolic process | 4.66e-01 | 1.00e+00 | 0.687 | 1 | 5 | 274 |
| GO:0006357 | regulation of transcription from RNA polymerase II promoter | 4.67e-01 | 1.00e+00 | 0.682 | 1 | 6 | 275 |
| GO:0003779 | actin binding | 4.67e-01 | 1.00e+00 | 0.682 | 1 | 7 | 275 |
| GO:0007283 | spermatogenesis | 4.68e-01 | 1.00e+00 | 0.676 | 1 | 6 | 276 |
| GO:0006954 | inflammatory response | 4.84e-01 | 1.00e+00 | 0.610 | 1 | 6 | 289 |
| GO:0016567 | protein ubiquitination | 4.96e-01 | 1.00e+00 | 0.561 | 1 | 5 | 299 |
| GO:0006200 | ATP catabolic process | 5.00e-01 | 1.00e+00 | 0.542 | 1 | 14 | 303 |
| GO:0043231 | intracellular membrane-bounded organelle | 5.33e-01 | 1.00e+00 | 0.410 | 1 | 8 | 332 |
| GO:0003682 | chromatin binding | 5.35e-01 | 1.00e+00 | 0.401 | 1 | 12 | 334 |
| GO:0007275 | multicellular organismal development | 5.46e-01 | 1.00e+00 | 0.359 | 1 | 5 | 344 |
| GO:0007155 | cell adhesion | 5.86e-01 | 1.00e+00 | 0.200 | 1 | 8 | 384 |
| GO:0006508 | proteolysis | 6.10e-01 | 1.00e+00 | 0.106 | 1 | 9 | 410 |
| GO:0045892 | negative regulation of transcription, DNA-templated | 6.23e-01 | 1.00e+00 | 0.057 | 1 | 14 | 424 |
| GO:0005886 | plasma membrane | 6.40e-01 | 1.00e+00 | -0.099 | 6 | 38 | 2834 |
| GO:0007165 | signal transduction | 6.43e-01 | 1.00e+00 | -0.107 | 2 | 17 | 950 |
| GO:0046872 | metal ion binding | 6.57e-01 | 1.00e+00 | -0.147 | 3 | 24 | 1465 |
| GO:0045893 | positive regulation of transcription, DNA-templated | 6.74e-01 | 1.00e+00 | -0.143 | 1 | 17 | 487 |
| GO:0000122 | negative regulation of transcription from RNA polymerase II promoter | 7.44e-01 | 1.00e+00 | -0.417 | 1 | 12 | 589 |
| GO:0005783 | endoplasmic reticulum | 7.56e-01 | 1.00e+00 | -0.468 | 1 | 9 | 610 |
| GO:0042803 | protein homodimerization activity | 7.60e-01 | 1.00e+00 | -0.484 | 1 | 11 | 617 |
| GO:0003700 | sequence-specific DNA binding transcription factor activity | 8.24e-01 | 1.00e+00 | -0.762 | 1 | 11 | 748 |
| GO:0006351 | transcription, DNA-templated | 8.87e-01 | 1.00e+00 | -0.845 | 2 | 25 | 1585 |
| GO:0005615 | extracellular space | 9.06e-01 | 1.00e+00 | -1.195 | 1 | 17 | 1010 |
| GO:0006355 | regulation of transcription, DNA-templated | 9.25e-01 | 1.00e+00 | -1.324 | 1 | 17 | 1104 |
| GO:0003677 | DNA binding | 9.59e-01 | 1.00e+00 | -1.615 | 1 | 26 | 1351 |
| GO:0016021 | integral component of membrane | 9.83e-01 | 1.00e+00 | -1.493 | 2 | 15 | 2483 |